<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NPG//DTD XML Article//EN" "NPG_XML_Article.dtd" [
<!ENTITY figf1 PUBLIC "-//NatureAmerica//FICI nsmb.2311-F1//EN" "nsmb.2311-F1" NDATA ITEM>
<!ENTITY figf2 PUBLIC "-//NatureAmerica//FICI nsmb.2311-F2//EN" "nsmb.2311-F2" NDATA ITEM>
<!ENTITY figf3 PUBLIC "-//NatureAmerica//FICI nsmb.2311-F3//EN" "nsmb.2311-F3" NDATA ITEM>
<!ENTITY figf4 PUBLIC "-//NatureAmerica//FICI nsmb.2311-F4//EN" "nsmb.2311-F4" NDATA ITEM>
<!ENTITY illus1 PUBLIC "-//NatureAmerica//FICI nsmb.2311-I1//EN" "nsmb.2311-I1" NDATA ITEM>
<!ENTITY illus2 PUBLIC "-//NatureAmerica//FICI nsmb.2311-I2//EN" "nsmb.2311-I2" NDATA ITEM>
]>
<article id="nsmb.2311" language="eng" publish="issue" relation="no">
<pubfm>
<jtl>Nature Structural &amp; Molecular Biology</jtl>
<vol>19</vol>
<iss>6</iss>
<idt>201206</idt>
<categ id="rv"/>
<pp><spn>577</spn><epn>585</epn><cnt>9</cnt></pp>
<issn type="print">1545-9993</issn>
<issn type="electronic">1545-9985</issn>
<cpg><cpy>2012</cpy><cpn>Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.</cpn></cpg>
<subject code="npg_subject_574"/>
<subject code="npg_subject_502"/>
<doi>10.1038/nsmb.2311</doi></pubfm>
<fm>
<atl>Translational control by changes in poly(A) tail length: recycling mRNAs</atl>
<aug>
<au><fnm>Laure</fnm><snm>Weill</snm><inits>L</inits><orf rid="a1"/></au>
<au><fnm>Eul&agrave;lia</fnm><snm>Belloc</snm><inits>E</inits><orf rid="a1"/></au>
<au><fnm>Felice-Alessio</fnm><snm>Bava</snm><inits>F -A</inits><orf rid="a1"/><orf rid="a2"/></au>
<cau><fnm>Ra&uacute;l</fnm><snm>M&eacute;ndez</snm><inits>R</inits><orf rid="a1"/><orf rid="a3"/><corf rid="c1"/></cau>
<aff><oid id="a1"/><org>Institute for Research in Biomedicine (IRB Barcelona)</org>, <cty>Barcelona</cty>, <cny>Spain</cny>.</aff>
<aff><oid id="a2"/><org>Center for Genomic Regulation (CRG), Pombeu Fabra University (UPF)</org>, <cty>Barcelona</cty>, <cny>Spain</cny>.</aff>
<aff><oid id="a3"/><org>Catalan Institution for Research and Advanced Studies (ICREA)</org>, <cty>Barcelona</cty>, <cny>Spain</cny>.</aff>
<caff><coid id="c1"/><email>raul.mendez@irbbarcelona.org</email></caff>
</aug>
<hst>
<pubdate type="aop" year="2012" month="06" day="05"/>
</hst>
<edsumm type="standfirst" publish="issue">
<title></title>
<p>Recent studies have revealed how poly(A) tail length and the selection of alternative polyadenylation sites contribute to translational control. This Review discusses how mechanisms of alternative polyadenylation, deadenylation and cytoplasmic polyadenylation are coordinated to modulate gene expression in inflammation, learning and memory acquisition, and early development.</p></edsumm>
<edsumm type="standfirst" publish="issue">
<title></title>
<p>Recent studies have revealed how poly(A) tail length and the selection of alternative polyadenylation sites contribute to translational control. This Review discusses how mechanisms of alternative polyadenylation, deadenylation and cytoplasmic polyadenylation are coordinated to modulate gene expression in inflammation, learning and memory acquisition, and early development.</p></edsumm>
<abs><p>Beyond the well-known function of poly(A) tail length in mRNA stability, recent years have witnessed an explosion of information about how changes in tail length and the selection of alternative polyadenylation sites contribute to the translational regulation of a large portion of the genome. The mechanisms and factors mediating nuclear and cytoplasmic changes in poly(A) tail length have been studied in great detail, the targets of these mechanisms have been identified&mdash;in some cases by genome-wide screenings&mdash;and changes in poly(A) tail length are now implicated in a number of physiological and pathological processes. However, in very few cases have all three levels&mdash;mechanisms, targets and functions&mdash;been studied together.</p></abs></fm>
<bdy>
<p>Virtually all mRNAs co-transcriptionally acquire a nontemplated poly(A) tail of approximately 250&ndash;300 adenosine residues. This nuclear polyadenylation is coupled with the endonucleolytic cleavage that defines their 3&prime; ends (reviewed in ref. <bibrinl rid="b1">1</bibrinl>). Although the addition of a poly(A) tail seems to occur by default, the subsequent control of its length is highly regulated both in the nucleus and in the cytoplasm, thereby contributing to the regulation of the stability, transport and translation of mature transcripts (reviewed in ref. <bibrinl rid="b2">2</bibrinl>). Once mRNAs reach the cytoplasm, the poly(A) tail acts synergistically with the 5&prime; cap to facilitate translation initiation through stabilization of the closed loop formed by the cap structure bound to the translation initiation factor 4F (eIF4F) complex (<bxr rid="bx1">Box 1</bxr>)<bibr rid="b3 b4"/>. Hence the integrity of 'circularized' mRNA is a common target of translation regulation<bibr rid="b5"/>. Although the abundance, post-translational modifications and competitors of the components of this closed-loop complex provide a general (that is, non&ndash;mRNA-specific) mode of translational regulation<bibr rid="b6"/>, transcript-specific translational control is determined by <i>cis</i>-acting regulatory sequences<bibr rid="b7"/>. These regulatory elements are present in the 5&prime; untranslated region (UTR) or even in the coding sequence, but most reside in the 3&prime; UTR. These motifs assemble mRNA-specific ribonucleoprotein complexes (mRNPs), including micro-ribonucleoprotein particles (miRNPs), deadenylation mRNPs and cytoplasmic polyadenylation complexes, all of which dynamically modulate the length of the poly(A) tail<bibr rid="b8 b9 b10 b11"/>. In turn, the length of the tail defines the extent of mRNA translation<bibr rid="b11 b12"/>. Therefore, the classical, linear view of poly(A) tail length regulation, in which all the mRNAs are polyadenylated by default during nuclear processing to be subsequently deadenylated as the first step toward degradation, reflects only some of the functions carried out by poly(A). A much more dynamic and bidirectional view of poly(A) tail acquisition, shortening and lengthening better reflects the potential of the poly(A) tail to regulate gene expression in time and space. Thus, even if nuclear poly(A) tail acquisition is a default process, the position at which the mRNA 3&prime; UTR is cleaved and polyadenylated is highly regulated for a large proportion of the genome, thereby determining the regulatory signals that will be present in the mature transcripts at their 3&prime; UTRs<bibr rid="b1"/> (<figr rid="f1">Fig. 1</figr>). These regulatory elements, in turn, will mediate mRNA deadenylation while stabilizing the translationally silent transcripts. Silent mRNPs accumulate and in many cases are localized to specific parts of the cell, to then be reactivated by cytoplasmic poly(A) tail elongation at the precise time and specific place where their encoded proteins are needed.</p>
<p>Not surprisingly, the potential of this cytoplasmic mechanism of gene expression regulation has been best exemplified in biological contexts. Examples of these situations are when a rapid and transient response to external stimuli or stress is required (inflammation), when localized expression of specific genes mediating cell polarity is needed (neurons) or when transcription, and therefore pre-mRNA processing, is silenced (germ cells and early development). In this review we will cover the basic mechanisms regulating alternative polyadenylation (APA), deadenylation and cytoplasmic polyadenylation and then analyze in more detail how these processes are coordinated to modulate gene expression in inflammation, learning and memory acquisition, and in early development.</p>
<sec level="2">
<sectitle>Alternative polyadenylation</sectitle>
<p>During nuclear processing of pre-mRNAs, more than half of the mammalian transcripts can be cleaved and polyadenylated in more than one site, thus generating 3&prime; UTRs of different lengths<bibr rid="b13"/>. The shortening of 3&prime; UTRs by APA is associated with proliferation and transformation, and this is in part due to the exclusion of miRNA binding sites in the 3&prime; UTRs of proto-oncogenes<bibr rid="b14 b15"/>. Shortening of 3&prime; UTRs is also observed at early stages of development as well as during reprogramming of induced pluripotent stem cells or in highly proliferative tissues such as testis<bibr rid="b16 b17"/>. In contrast, transcripts from late developmental stages and differentiated nonproliferative cells tend to include longer 3&prime; UTRs<bibr rid="b18 b19 b20"/> (<figr rid="f1">Fig. 1</figr>).</p>
<p>For the co-transcriptional selection of the cleavage and polyadenylation site, the cleavage and polyadenylation machinery (<bxr rid="bx2">Box 2</bxr> illustration, panels <b>a</b> and <b>b</b>) is deposited on the nascent transcript upon exposure of the cleavage and polyadenylation <i>cis</i>-acting elements. Although the forces driving the selection of the APA site are still unclear, the conservation of <i>cis</i>-elements flanking the alternative proximal polyadenylation sites suggests that the selection of the upstream APA sites is promoted by additional factors, whereas distal APA sites are the default polyadenylation site<bibr rid="b21"/> (<figr rid="f1">Fig. 1</figr>). Recently, the neuron-specific splicing regulator protein Nova2 has been identified as one of these <i>trans</i>-acting factors<bibr rid="b19"/>. Nova2 binding next to the distal polyadenylation site enhances its use, whereas Nova2 binding next to the proximal polyadenylation site inhibits its use. Thus, Nova2 consistently favors the formation of long 3&prime; UTRs, thereby suggesting a dual function of this protein by outcompeting core elements of the cleavage and polyadenylation machinery and displacing negative regulators.</p>
</sec>
<sec level="2">
<sectitle>Repressing mRNA translation by deadenylation</sectitle>
<p>Deadenylation, followed by decapping and degradation, is the first and essential step in nuclear and cytoplasmic mechanisms for silencing aberrant or no longer needed transcripts (reviewed in ref. <bibrinl rid="b22">22</bibrinl>). However, deadenylation is not necessarily linked to mRNA degradation. Deadenylated mRNAs can also be stable but translationally silent and can be reactivated by cytoplasmic polyadenylation, thus resuming gene expression even in the absence of transcription<bibr rid="b23"/>. Regardless of the final outcome, whether mRNA degradation or translational silencing, deadenylation is carried out through a complex combinatorial arrangement of <i>cis</i>-acting elements recognized by a large number of RNA-binding proteins (RNA-BPs), which in many cases compete with each other and may even have opposite functions. These RNA-BPs recruit catalytically active deadenylases (reviewed in ref. <bibrinl rid="b24">24</bibrinl>), mainly poly(A) RNase (PARN; also known as deadenylating nuclease (DAN)) and the CCR4&ndash;NOT complex. The most common <i>cis</i>-acting elements promoting deadenylation are described below.</p>
<p><b>AU-rich elements.</b> Consisting mainly of 5&prime;-AUUUA-3&prime; pentamer repeats in U-rich regions, AU-rich elements (AREs) are present in 5&ndash;8% of human genes<bibr rid="b25"/>. Although AREs are recognized by about 30 ARE-binding proteins (ARE-BPs), the predominant one is tristetraprolin (TTP, also known as Tis11 or Zfp36), which recruits the CCR4&ndash;NOT complex<bibr rid="b26"/> (<figr rid="f2">Fig. 2a</figr>). A <i>Xenopus laevis</i> paralog of TTP, C3H-4, promotes the meiosis-specific deadenylation of ARE-containing maternal mRNAs by the CCR4&ndash;NOT complex<bibr rid="b27"/>. In contrast, other ARE-BPs, such as KSRP and AUF1, recruit PARN to promote deadenylation<bibr rid="b28"/> (<figr rid="f2">Fig. 2a</figr>). Although the recruitment of the deadenylase is often coupled to exosome-mediated mRNA degradation, some ARE-BPs, such as the ELAV family member HuR, promote deadenylation while stabilizing the mRNA<bibr rid="b29"/>.</p>
<p><b>Cytoplasmic polyadenylation elements.</b> Consisting of the 5&prime;-UUUUAU-3&prime; or 5&prime;-UUUUAAU-3&prime; sequence, cytoplasmic polyadenylation elements (CPEs) are present in 15&ndash;20% of the vertebrate genomes<bibr rid="b11"/>, and they mediate deadenylation of maternal mRNAs during vertebrate oogenesis. CPEs are recognized by the CPE binding proteins (CPEBs). CPEB1 is a dual function RNA-BP that, when not phosphorylated, recruits PARN<bibr rid="b30"/> to deadenylate and repress maternal mRNAs (<figr rid="f2">Fig. 2b</figr>). However, once activated, CPEB1 promotes cytoplasmic polyadenylation<bibr rid="b31 b32"/> (<bxr rid="bx2">Box 2</bxr>). CPEB1 also forms a complex with eIF4E-T<bibr rid="b33"/> (<figr rid="f2">Fig. 2b</figr>), a homolog of <i>Drosophila melanogaster</i> Cup, which induces deadenylation through the CCR4&ndash;NOT complex<bibr rid="b34"/>. CPEB3 recruits the CCR4&ndash;NOT complex through its interaction with the antiproliferative factor Tob<bibr rid="b35"/>.</p>
<p><b>Pumilio-binding sites.</b> Present in 12% of the yeast transcriptome<bibr rid="b36"/>, Pumilio-binding sites are recognized by PUF family members Pumilio and FBF, and they promote deadenylation by both the CCR4&ndash;NOT complex<bibr rid="b37 b38"/> and PARN<bibr rid="b39"/>.</p>
<p><b>Embryonic deadenylation element.</b> The embryonic deadenylation element (EDEN) is a GU-rich sequence recognized by the EDEN-binding protein (EDEN-BP), also known as CUG-BP. This protein accumulates after fertilization and induces the deadenylation of mRNAs involved in the cell cycle or oocyte maturation, thus restricting their activity to germ cells<bibr rid="b40"/>. Although the deadenylase recruited by EDEN-BP is still unknown in <i>X. laevis</i> oocytes, in mammalian cells, CUG-BP1 is bound by PARN<bibr rid="b41"/>.</p>
<p><b>miRNA target sites.</b> miRNAs promote translational repression through RISC component GW182 and the CCR4&ndash;NOT complex<bibr rid="b8 b9 b10"/> (<figr rid="f2">Fig. 2c</figr> and see the review by Fabian &amp; Sonenberg in this issue<bibr rid="b42"/> for more details). However, the coordination of deadenylation and translational repression is still controversial. Thus, although some lines of evidence point to deadenylation as a cause, others suggest it is a consequence of translational repression<bibr rid="b43 b44 b45"/>.</p>
<p>Interestingly, multiple deadenylation pathways are coordinated to regulate subpopulations of mRNAs. For example, TTP and HuR can either potentiate<bibr rid="b46 b47"/> or inhibit<bibr rid="b48"/> miRNA-mediated repression of specific mRNAs (<figr rid="f2">Fig. 2d</figr>). This may be a general combinatorial mechanism, as miRNAs and CPEB1 targets show an over-representation of ARE-containing mRNAs<bibr rid="b27 b49"/>.</p>
</sec>
<sec level="2">
<sectitle>Translational reactivation by cytoplasmic polyadenylation</sectitle>
<p>Reactivation of stored, silenced and deadenylated mRNAs can take place without poly(A) tail elongation through RNA-BPs such as DAZL, which recruits the poly(A) binding protein (PABP) independently of the poly(A) tail<bibr rid="b50"/>, or by SLBP, which directly stabilizes eIF4G<bibr rid="b51"/>. However, in most cases, translational reactivation requires cytoplasmic poly(A) tail elongation. The best-characterized mechanism of cytoplasmic polyadenylation is mediated by CPEB1 (ref. <bibrinl rid="b52">52</bibrinl>) (<bxr rid="bx2">Box 2</bxr> illustration, panel <b>c</b>). Since the identification of CPEB1 as a translational activator in meiotic oocytes, the number of potential targets for this protein has expanded from roughly a dozen maternal mRNAs to cover up to 20% of vertebrate genomes<bibr rid="b11"/>. Moreover, three additional members of the family (CPEB2, CPEB3 and CPEB4) have been identified. All CPEBs contain similar zinc finger&ndash;like and RRM domains but differ considerably in their regulatory regions and expression patterns<bibr rid="b53 b54"/>. All CPEBs recognize similar <i>cis</i>-acting elements, although with different affinities<bibr rid="b55 b56 b57"/>, and bind to overlapping populations of mRNA targets<bibr rid="b55 b56 b57 b58 b59"/>.</p>
<p>Phosphorylation of CPEB1 increases its affinity for CPSF<bibr rid="b32"/> and decreases its binding to PARN<bibr rid="b30"/>, thus switching its function from repressor to activator of translation (<bxr rid="bx2">Box 2</bxr> illustration, panel <b>c</b>). CPEB1 activation is driven by Aurora A kinase in oocytes<bibr rid="b31"/> and at post-synaptic densities<bibr rid="b60"/>, although &alpha;CAMKII has also been reported to activate CPEB1 in neurons<bibr rid="b61"/>. CPEB4 phosphorylation by an unknown kinase is also required for its activation<bibr rid="b55 b56"/>, whereas CPEB3 is activated by monoubiquitination<bibr rid="b59"/>. Interestingly, the mRNAs encoding CPEBs are themselves targets for cytoplasmic polyadenylation<bibr rid="b56"/> and miRNAs<bibr rid="b62"/>. In addition to CPEs, other elements have been described to mediate cytoplasmic polyadenylation; however, the mechanisms are still not well defined<bibr rid="b63 b64"/>.</p>
<p>Although we are still far from delineating the RNA maps of translational control by poly(A) tail changes, it is clear that APA, deadenylation and cytoplasmic polyadenylation are used combinatorially to define the temporal and spatial regulation of mRNAs. Below, we describe examples of regulated mRNAs in three model systems: inflammation, in which the function of deadenylation has been extensively studied; memory consolidation, which requires local translation by cytoplasmic polyadenylation; and germ cells, which have been instrumental in elucidating most of the mechanisms of cytoplasmic polyadenylation.</p>
</sec>
<sec level="2">
<sectitle>The poly(A) tail in inflammation</sectitle>
<p>Acute inflammation is a rapid and robust immune response to infection and injuries. However, this response also needs to be limited in time to prevent the detrimental effects of chronic inflammation. In many cases, this regulation is accomplished through the translational control of stored mRNAs, thus avoiding the time-consuming nuclear control mechanisms of transcription, splicing and transport (reviewed in ref. <bibrinl rid="b65">65</bibrinl>). Arguably the most commonly used translational control mechanism in inflammation relies on the deadenylation of specific mRNAs such as tumor necrosis factor &alpha; (TNF&alpha;) and cyclooxygenase-2 (COX-2), which are stabilized and stored to be reactivated later during inflammation.</p>
<p><b>Deadenylation in inflammation.</b>TNF&alpha; translation is regulated through AREs in its 3&prime; UTR and by a set of ARE-BPs that direct distinct outcomes in mRNA stability and translation. The relevance of these AREs is highlighted in a mouse model lacking these elements in the 3&prime; UTR. The absence of these AREs causes high levels of circulating TNF&alpha; and therefore chronic inflammation<bibr rid="b66"/>. TNF&alpha; AREs recruit TTP, which induces rapid deadenylation and mRNA decay under normal conditions<bibr rid="b67"/>. Inflammation leads to the expression of TNF&alpha; by inactivation of TTP<bibr rid="b68"/> and promotes HuR translocation to the cytoplasm, which causes the repression and stabilization of TNF&alpha; mRNA<bibr rid="b69"/>. These apparent opposite responses allow a brief burst of TNF&alpha; expression, followed by rapid reactivation. In addition to AREs, the TNF&alpha; 3&prime; UTR is also regulated by miRNAs. For example, miR-16 cooperates with TTP in the destabilization of TNF&alpha;<bibr rid="b46"/>. Surprisingly, miR-155 also targets the TNF&alpha; 3&prime; UTR but promotes translation through an unknown mechanism<bibr rid="b70"/>.</p>
<p>COX-2, a key regulatory enzyme in prostaglandin production associated with inflammatory diseases and cancers, is also regulated by ARE-BPs. CUGBP2 binds the AREs within the COX-2 3&prime; UTR and inhibits translation while stabilizing the mRNA<bibr rid="b71"/>, whereas miR-16 induces mRNA decay<bibr rid="b46"/>. HuR antagonizes both CUGBP2 and miR-16 (refs. <bibrinl rid="b71">71</bibrinl>,<bibrinl rid="b72">72</bibrinl>). This situation reflects a common scenario in ARE-mediated translational control, wherein several factors (proteins or miRNAs) with opposite functions or effects compete for binding to target mRNAs. The complexity of these interactions is further increased by cross-regulation at the level of the <i>trans</i>-acting factors themselves, including miR-16 and HuR<bibr rid="b73"/>.</p>
<p><b>APA in inflammation.</b> The inclusion or exclusion of regulatory elements in mature mRNA can be modulated through APA events during inflammation. Genome-wide analysis revealed that a general shortening of 3&prime; UTRs occurs upon activation of CD4<super>+</super> T lymphocytes<bibr rid="b14"/>. A similar switch is observed for the 3&prime; UTR of the NF-ATc mRNA in immortalized human T-cells upon their activation<bibr rid="b74"/>. This shortening of 3&prime; UTRs correlates with increased levels of the nuclear polyadenylation factor CstF-64 during both macrophage activation<bibr rid="b75"/> and B-cell differentiation. A number of ARE mRNAs, including COX-2 (ref. <bibrinl rid="b76">76</bibrinl>), undergo APA, leading to the differential inclusion of AREs from the mature 3&prime; UTR.</p>
<p><b>Cytoplasmic polyadenylation in inflammation.</b> Surprisingly little is known about how mRNAs, which are deadenylated but stabilized in basal conditions, are reactivated upon inflammation. However, it is thought that reactivation may require cytoplasmic elongation of mRNA poly(A) tails. Interestingly, bioinformatics analysis shows that more than 20 genes related to inflammation in humans and mice contain CPEs in their 3&prime; UTRs<bibr rid="b11"/> (<url>http://genome.crg.es/CPE/</url>). Accordingly, IL-6 and p53 are regulated by components of the cytoplasmic polyadenylation machinery<bibr rid="b77 b78"/>. However, the possible contribution of cytoplasmic polyadenylation to inflammation remains to be determined.</p>
</sec>
<sec level="2">
<sectitle>Poly(A) tail in learning and memory</sectitle>
<p>Local translation at the synapses is required to convert short-term memory into long-term memory. Neurons must therefore repress the translation of mRNAs encoding synaptic proteins during their transport and yet quickly activate them in response to synaptic stimulation. For this purpose, neurons have developed a number of mRNA-specific translational control mechanisms using both general translation factors and specific mRNA-binding proteins (reviewed in ref. <bibrinl rid="b79">79</bibrinl>). Among these, translational control by the CPEB family of proteins and cytoplasmic polyadenylation are key regulators of synaptic plasticity and memory formation.</p>
<p><b>Cytoplasmic polyadenylation in neurons.</b> In mammalian neurons, CPEB1 represses, transports and activates the translation of synaptic transcripts<bibr rid="b60 b80"/>. First, mRNAs are repressed in the soma and then transported to post-synaptic densities through the interaction of CPEB1 with the molecular motors dynein and kinesin. Finally, upon synaptic stimulation, local translation is activated by cytoplasmic polyadenylation<bibr rid="b81"/>. Accordingly, CPEB1 knockout mice show reduced long-term potentiation in hippocampal Schaffer CA-1 neurons and also have a deficit in memory extinction<bibr rid="b82 b83"/>.</p>
<p>The most widely studied locally translated neuronal transcript encodes the &alpha;-subunit of calcium/calmodulin-dependent protein kinase II (&alpha;CaMKII) (<figr rid="f3">Fig. 3</figr>), which localizes at the dendrites of hippocampal neurons and whose synthesis in the synapse is required for memory consolidation. &alpha;CaMKII contains CPEs in its 3&prime; UTR, and it is polyadenylated by CPEB1 in rat brain under stimulation with light<bibr rid="b80"/>. In addition, &alpha;CaMKII phosphorylates and activates CPEB1 (ref. <bibrinl rid="b84">84</bibrinl>), thus generating a local positive feedback loop to stabilize the synaptic inputs<bibr rid="b85"/>. The relevance of &alpha;CaMKII mRNA localization and its local translation activation is demonstrated in a mouse model expressing a &alpha;CaMKII transcript lacking the wild-type 3&prime; UTR. This chimeric mRNA results in reduced protein levels as a result of disrupted localization of mRNA to dendrites. Consequently, late-phase long-term potentiation, spatial memory and long-term memory are impaired in these mice<bibr rid="b86"/>. More recently, a number of other transcripts, including c-Jun, BDNF and tPA mRNAs, have been characterized as CPEB1 targets in the nervous system<bibr rid="b87 b88 b89"/>. CPEB3, activated by Neuralized1-mediated monoubiquitination, is highly expressed in the brain and regulates the translation of GluA1 and GluA2 mRNAs in hippocampal neurons<bibr rid="b57 b59"/>. CPEB4 is also highly expressed in neurons; however, its possible function or regulation has not yet been explored<bibr rid="b53 b57"/>.</p>
<p>CPEB orthologs in invertebrates have also been implicated in neuronal activity. <i>Aplysia</i> sensory neurons contain a CPEB ortholog that is required for long-term facilitation and that exhibits prion-like properties. Additionally, only the aggregated CPEB is active<bibr rid="b90"/>. An amyloid-like oligomer of Orb2, the <i>D. melanogaster</i> CPEB2-4 ortholog, is required for long-term memory<bibr rid="b91 b92"/>. Genome-wide screenings for Orb2 targets in neurons identified a large number of transcripts implicated in neuronal growth, synapse formation, synaptic function, proteolysis and Orb2 itself<bibr rid="b93"/>.</p>
<p><b>Deadenylation in neurons.</b> Despite the large amount of evidence highlighting the relevance of cytoplasmic polyadenylation in synaptic stimulation, very little is known about how these locally activated transcripts are deadenylated before their localization. Although CPEB1 and CPEB3 mediate deadenylation, this has not been shown in neurons. It is not known whether CPEB2 and CPEB4, Orb2 or <i>Aplysia</i> CPEB can mediate deadenylation. In contrast, some evidence points to a relevant role of miRNAs and the RISC pathway in neuronal deadenylation, repression and localization of mRNAs, such as the one encoding &alpha;CaMKII<bibr rid="b94"/> (<figr rid="f3">Fig. 3</figr>).</p>
<p><b>APA in neurons.</b> In cultured neurons, a subset of transcripts undergo truncation to internal polyadenylation sites upon membrane depolarization<bibr rid="b95"/>.Thus, APA of BDNF and &alpha;CaMKII mRNAs generate two CPE-containing alternative 3&prime; UTRs that are differentially localized and translated in neurons (<figr rid="f3">Fig. 3</figr>). The transcript variants harboring the shorter 3&prime; UTRs localize to the soma, whereas the longer 3&prime; UTRs mediate the localization of mRNAs to dendrites. Thus, the regulatory elements included in the long isoforms harbor the information required for translational regulation and localization<bibr rid="b20"/>. A transgenic mouse with an intact BDNF coding sequence but with only the short 3&prime; UTR displays normal levels of BDNF, but the protein is mislocalized, which results in neuronal abnormalities<bibr rid="b20"/>. Interestingly, BDNF 3&prime; UTRs, particularly its longest 3&prime; UTR, are targeted by miRNA-206, which also regulates BDNF expression during myoblast differentiation, lung development and innervation<bibr rid="b96 b97"/>.</p>
</sec>
<sec level="2">
<sectitle>The poly(A) tail in germ cells and early development</sectitle>
<p>Immature vertebrate oocytes arrest at prophase of meiosis I. During oogenesis, they synthesize and store up to 50% of the genome as dormant mRNAs<bibr rid="b98"/>. Once these maternal mRNAs have been stored, transcription ceases. These mRNAs will later drive oocyte re-entry into meiosis and early embryonic mitosis<bibr rid="b23"/>, which rely on massive translational reprogramming<bibr rid="b99"/>.</p>
<p>Meiotic phase transitions (prophase I, metaphase I and metaphase II) and the concomitant polarization events are orchestrated by sequential waves of translational activation and repression, which are, in turn, reinforced by positive and negative translational feedback loops that ensure coordinated and unidirectional regulation of gene expression<bibr rid="b11 b27"/>. The most common mechanism to activate the translation of maternal mRNAs is by CPEB-dependent cytoplasmic polyadenylation. However, not all the CPE-regulated mRNAs are activated at the same time. A highly precise order of activation, and in some cases inactivation, of cytoplasmic polyadenylation is required to ensure that the right protein is present at the proper time, thus allowing phase transitions to take place in an orderly manner. The sequential activation of these maternal mRNAs is defined by the number and position of CPEs with respect to the polyadenylation site, combined with deadenylation-driven negative feedback loops<bibr rid="b11 b27"/> (<figr rid="f4">Fig. 4</figr>).</p>
<p><b>Cytoplasmic polyadenylation and deadenylation in development.</b> During <i>X. laevis</i> oocyte maturation, the proper activation of mRNAs is achieved by the activity of three proteins: CPEB1, CPEB4 and C3H-4 (refs. <bibrinl rid="b11">11</bibrinl>,<bibrinl rid="b27">27</bibrinl>,<bibrinl rid="b56">56</bibrinl>). First, CPEB1 activates two sets of mRNAs, the first, named 'early', takes place before metaphase I entry, whereas the second, named 'late', occurs at metaphase I (<figr rid="f4">Fig. 4</figr>). At metaphase I, CPEB1 is targeted for degradation, but CPEB4, which is translated at metaphase I, takes over from CPEB1. Thus, CPEB4 polyadenylates the CPE-containing mRNAs from interkinesis until metaphase II arrest. Interestingly, cytoplasmic polyadenylation waves are reinforced by positive translation feedback loops that activate the synthesis of components of the cytoplasmic polyadenylation machinery (such as CPEB4 and GLD-2), which are themselves encoded by CPE-containing mRNAs<bibr rid="b56 b100"/>. In addition, during early activation, C3H-4 is produced and triggers the deadenylation of ARE-containing mRNAs. From the combination of C3H-4 and the early and late polyadenylation, two new activation time frames arise. The presence of AREs in early activated mRNAs causes their deadenylation from metaphase I onward. Although in the case of late activated mRNAs, C3H-4 delays their full polyadenylation to a later stage. Moreover, C3H-4 targets its own mRNA, thus establishing a negative feedback loop<bibr rid="b28"/>. Although the poly(A)-dependent regulation of several dozen maternal mRNAs has been studied<bibr rid="b11 b27"/>, only some of the key ones driving meiotic progression are described in <figr rid="f4">Figure 4</figr>.</p>
<p>Upon fertilization, EDEN-BP drives the deadenylation of maternal mRNAs<bibr rid="b101"/>. In <i>D. melanogaster</i> embryogenesis, CCR4 has been shown to interact with several RNA-BPs, such as Pumilio<bibr rid="b37"/> and Nanos<bibr rid="b38"/>, and with components of the miRNA pathway. The mRNA of Nanos protein is targeted by the RNA-BP Smaug and Piwi-interacting RNAs that recruit the CCR4&ndash;NOT complex. Disruption of this mechanism leads to an aberrant localization of Nanos protein<bibr rid="b102"/>. In zebrafish, miRNA-dependent deadenylation and decay of maternal mRNAs is a crucial step to establish tissue-specific expression and cellular reprogramming during the maternal-to-zygotic transition. Thus, miR-430 induces deadenylation and degradation of several hundred maternal mRNA targets and is thus essential for primordial germ cell migration<bibr rid="b103 b104"/>.</p>
<p><b>APA in development.</b> In early development, APA promotes the shortening of 3&prime; UTRs. Thus, in mouse, before embryonic day 8 (E8.0), 3&prime; UTRs tend to use the shortest variants, which become elongated thereafter and until birth<bibr rid="b16"/>. Interestingly, this regulation appears to be conserved throughout evolution, as it has also been shown in <i>Caenorhabditis elegans</i><bibr rid="b18"/> and in <i>D. melanogaster</i> development. In particular, in <i>D. melanogaster</i>, this regulation is specific for neural tissues and leads to a substantial increase in the inclusion of Pumilio-binding sites, thus providing a platform for translational regulation<bibr rid="b105"/>.</p>
</sec>
<sec level="2">
<sectitle>Conclusions</sectitle>
<p>In recent years, many 3&prime; UTR&ndash;localized elements that regulate the dynamics of the poly(A) tail length and their cognate factors have been identified. Nevertheless, some key questions still need to be addressed, including the mechanism underlying APA regulation. Indeed, we are far from having a comprehensive understanding of this mechanism of gene expression regulation and its relevance in physiological and pathological conditions. Also, the full cycle of only very few mRNAs&mdash;from nuclear processing to translational repression, mRNA localization, reactivation and inactivation-degradation&mdash;has been well defined. Neither have all the <i>trans</i>-acting factors and their regulation been determined. Conversely, only for very few of these RNA-BPs have the mRNA targets been identified in a genome-wide manner, covering 5&ndash;20% of the genome in each case<bibr rid="b11 b36 b106"/>. These limitations undermine our ability to delineate the molecular circuits of gene-expression regulation at a genomic level.</p>
<p>Nevertheless, current information indicates that these circuits are complex and have a large regulatory potential for gene expression. This observation, together with the fact that most 3&prime; UTRs contain multiple independent sets of <i>cis</i>-acting elements (that is, miRNA-binding sites, AREs and CPEs), demonstrates the potential degree of interconnectivity of this circuit. An additional layer of complexity derives from the fact that in many cases, the <i>trans</i>-acting factors, or their regulators (such as kinases), are encoded by mRNAs containing similar sets of <i>cis</i>-acting elements, thus establishing positive and negative feedback loops at the translational level<bibr rid="b11 b27"/>. Delineating the polyadenylation circuits and their regulation will not only define the physiological relevance of the poly(A) tail in gene expression but also its contribution to various pathologies and its therapeutic potential. Indeed, some pathologies have already been linked to the misregulation of poly(A) tail length. Thus, point mutations in polyadenylation sites result in APA site selection that is associated with IPEX syndrome<bibr rid="b107"/>, and changes in APA for proto-oncogene mRNAs are associated with transformation and cancer<bibr rid="b15"/>. Tumor development has also been related to defects in translational control by ARE-BPs<bibr rid="b108 b109"/> and CPEB4 (ref. <bibrinl rid="b58">58</bibrinl>), and miRNAs are involved in an increasing number of pathologies (for examples, see ref. <bibrinl rid="b110">110</bibrinl>). As our knowledge of the translational circuits regulated by poly(A) tail-length dynamics improves, the number of related pathologies and therefore the therapeutic potential of the factors regulating poly(A) tail length are likely to increase proportionally.</p>
<p><i>Note added in proof:</i> A recent publication shows that PABPN1 binds upstream nonconsensus polyadenylation sites, precluding the recruitment of cleavage and polyadenylation machinery and therefore favoring the use of distal polyadenylation sites<bibr rid="b118"/>.</p>
</sec>
</bdy>
<bm><objects>
<fig id="f1" type="bmp" entname="figf1">
<figtl>Model for APA regulation.</figtl>
<caption><p>The 3&prime; UTRs of pre-mRNAs harbor different types of <i>cis</i>-elements that regulate APA through the recruitment of the corresponding <i>trans</i>-acting factors. (<b>a</b>) In late developmental stages and cell differentiation, the use of proximal and weak polyadenylation (wPA) sites can be inhibited by <i>trans</i>-acting factors (A,B) binding to sites in their proximity (X,Y). The use of distal and strong polyadenylation (sPA) sites can be enhanced by <i>trans</i>-acting factors (C,D) binding to the upstream element (USE) and downstream element (DSE). This event may favor the recruitment of nuclear polyadenylation factors CPSF and CstF to the sPA site and the U/GU-rich element, respectively. Consequently, regulatory elements (REs) present in the 3&prime; UTR are retained in the mature transcript, mediating relevant biological processes, such as mRNA localization, and leading to regulated mRNA translation. (<b>b</b>) In early developmental stages during cellular proliferation and transformation, the use of proximal and wPA signals can be enhanced by <i>trans</i>-acting factors (E,F) binding to sites in their proximity (X,Y). This event can favor the recruitment of CPSF to the proximal and wPA signals, and CstF to the U/GU-rich element. Consequently, the 3&prime; UTRs are shortened and downstream regulatory elements are excluded from the mature transcript.</p></caption></fig>
<fig id="f2" type="bmp" entname="figf2">
<figtl>Examples of cytoplasmic deadenylation.</figtl>
<caption><p>(<b>a</b>) AREs drive mRNA deadenylation. The binding of the ARE-BPs (in blue) TTP and KSRP on AREs induces rapid mRNA deadenylation by the recruitment of the deadenylases CCR4&ndash;NOT complex and PARN (in green), respectively. The binding of HuR represses translation and stabilizes the transcript by inhibiting exosome recruitment. (<b>b</b>) CPEB-mediated repression of maternal dormant mRNAs requires two CPEs in the 3&prime; UTR. In <i>X. laevis</i> oocyte early stages (I&ndash;IV), CPEB1 forms a complex with several translation repressors: Pat1, p54, Rap55 and eIF4E-T. Given that Cup, the eIF4E-T homolog in <i>D. melanogaster</i> , induces deadenylation through the CCR4&ndash;NOT complex, we speculate that eIF4E-T acts in a similar manner. In stage VI oocytes, CPEB1 bound to CPE and CPSF bound to the polyadenylation site form a complex with GLD-2, ePAB, Symplekin and PARN. PARN antagonizes GLD-2 to keep maternal mRNAs deadenylated. (<b>c</b>) miRNA binding guides the RISC complex (which comprises AGO and GW182) to induce CCR4&ndash;NOT&ndash;mediated deadenylation. Direct interaction between GW182 and Not1 leads to deadenylation of the targeted mRNA. (<b>d</b>) A combination of <i>cis</i>-elements silences an mRNA. miRNAs and TTP bind AU-rich sequences and collaborate to recruit the CCR4&ndash;NOT complex.</p></caption></fig>
<fig id="f3" type="bmp" entname="figf3">
<figtl>Recycling of &alpha;CaMKII mRNA in neurons.</figtl>
<caption><p>APA of &alpha;CaMKII mRNA generates two transcripts with 3&prime; UTRs of different lengths (1). Both transcripts are polyadenylated in the nucleus, but the composition of the <i>cis</i>-elements in their 3&prime; UTR modifies their cytoplasmic fates. The short isoform is translated mainly in the soma (2), whereas miRNA binding sites, AREs and CPE mediate deadenylation, repression (3) and transport (4) of the long transcript to dendrites. Upon neuronal stimulation in the post-synaptic densities (PSD), CPEB1 promotes &alpha;CaMKII mRNA polyadenylation (5) and &alpha;CAMKII local translation (6).</p></caption></fig>
<fig id="f4" type="bmp" entname="figf4">
<figtl>Recycling of maternal mRNAs in oocytes during meiosis.</figtl>
<caption><p>In immature oocytes, CPE mRNAs are deadenylated. Upon progesterone stimulation, CPEB, through three sequential waves of cytoplasmic polyadenylation, regulates the three key activities that drive meiotic progression: maturation promoting factor (MPF, a Cdc2 cyclin B heterodimer), the anaphase-promoting complex/cyclosome (APC/C), and cytostatic factor (CSF). CPEB1 polyadenylates the early mRNAs that contain a CPE that does not overlap with the polyadenylation site, whereas the late mRNAs have a CPE overlapping with the polyadenylation site. The early wave is required for MPF activation, which catalyzes meiosis re-entry. At metaphase I (MI), APC/C activated by MPF induces cyclin B destruction. Nevertheless, early activation of mitotic regulator Emi1 inhibits APC/C and therefore prevents MPF inhibition. Then C3H-4, encoded by an early mRNA, progressively deadenylates the early mRNAs that contain AREs (that is, Emi1 mRNA) from metaphase I on, thereby allowing the activation of APC/C during interkinesis. At the same time, increased synthesis of cyclins B1 and B4 results in only a partial inactivation of MPF during interkinesis to prevent S phase entry. Finally, CSF formed by a complex including Emi2 protein inhibits APC/C to stabilize MPF activity in metaphase II (MII). Emi2 mRNA is weakly polyadenylated before metaphase II as a result of the activity of C3H-4 and is only fully polyadenylated at later stages ('late-late') by CPEB4.</p></caption></fig>
<bx id="bx1">
<bxtitle>Regulation of translation initiation and the pseudo-circularization of mRNA</bxtitle>
<p>Translation is a complex process comprised of initiation, elongation and termination phases, requiring hundreds of polypeptides, including conserved eukaryotic translation initiation factors (eIFs). The initiation phase includes all events required for the assembly of a complete (80S) ribosome at the start codon of the mRNA. The recognition of the mRNAs by eIFs is directly mediated by two features present at each end of all nuclear transcribed eukaryotic mRNAs (reviewed in refs. <bibrinl rid="b111">111</bibrinl>,<bibrinl rid="b112">112</bibrinl>). The 5&prime; end contains an m<super>7</super>Gppp group termed the 5&prime; cap, and the 3&prime; end is blocked by a long stretch of adenine residues (poly(A) tail). First, translation initiation requires the association of the eIF4F complex with the cap. This complex consists of the cap-binding factor eIF4E, the RNA helicase eIF4A and the scaffolding protein eIF4G. The recruitment of eIF4F is stabilized by the binding of eIF4G to the 3&prime; PABP, and the resulting pseudo-circularization of mRNA molecules<bibr rid="b113"/>. Next, the 43S pre-initiation complex (which includes the 40S ribosomal subunit and associated eIFs) is recruited through the interaction between eIF3 and the mRNA-bound eIF4F. The 43S scans the 5&prime; untranslated region (5&prime; UTR) until it encounters an initiation codon in an optimal context; the 60S ribosomal subunit then joins to form a translationally competent 80S ribosome. During the elongation phase, the ribosome 'reads' the coding sequence to produce the encoded polypeptide. Finally, when the ribosome reaches the stop codon, termination takes place. As a consequence, the ribosome and the polypeptide dissociate from the mRNA<bibr rid="b112 b114"/>.</p>
<p><illusr rid="illus1"/></p>
<p>Although almost every step of this process is a target for regulation, translation initiation is rate-limiting<bibr rid="b112"/>. Accordingly, it is the main target for translational control mechanisms<bibr rid="b115"/>. miRNA binding sites and AREs target this loop by promoting deadenylation, thereby disrupting the binding of PABP on the poly(A) tail and mRNA circularization. These events greatly decrease the translation efficiency. The CPE and polyadenylation site promote cytoplasmic polyadenylation (see <bxr rid="bx2">Box 2</bxr>), although CPE can also contribute to mRNA deadenylation.</p></bx>
<bx id="bx2">
<bxtitle>Nuclear versus cytoplasmic polyadenylation machineries</bxtitle>
<p>Nuclear cleavage (see illustration, part <b>a</b>). Nuclear polyadenylation, coupled with endonucleolytic cleavage of the nascent transcript, is driven by two core <i>cis</i>-acting elements surrounding the cleavage site (CA): the polyadenylation site (PA), which is 25&ndash;30 nucleotides upstream of the cleavage site, and a U- and GU-rich sequence (U/GU-rich), 30 nucleotides downstream of the cleavage site. Both elements are present in almost all mRNAs and are recognized cooperatively by two multisubunit factors. The cleavage and polyadenylation specificity factor (CPSF) binds to the polyadenylation site, and the cleavage stimulation factor (CstF) binds to the U/GU-rich sequence. In addition, cleavage factors I and II (CF I and CF II), RNA polymerase II (POL II), PABP, Symplekin and poly(A) polymerase (PAP) constitute the cleavage and polyadenylation complex (reviewed in ref. <bibrinl rid="b1">1</bibrinl>).</p>
<p>Nuclear polyadenylation (see illustration<illusr rid="illus2"/>, part <b>b</b>). Once the pre-mRNA is cleaved, the poly(A) tail is elongated, first in a distributive manner until PABP binds, and then with processive activity, until it reaches a length of 250&ndash;300 nucleotides (reviewed in ref. <bibrinl rid="b1">1</bibrinl>).</p>
<p>CPEB1-mediated cytoplasmic polyadenylation (see illustration, part <b>c</b>). Cytoplasmic polyadenylation targets mRNAs that already contain a short poly(A) tail, usually 20- to 30-nucleotides long. This process requires two elements in the 3&prime; UTR of responding mRNAs. The first one is the same polyadenylation site used in nuclear polyadenylation, also bound by CPSF. The second is the CPE, present only in specific mRNAs. Phosphorylated CPEB1 increases the recruitment of CPSF to the polyadenylation site. Next, both CPEB1 and CPSF recruit the cytoplasmic poly(A) polymerase GLD-2 to elongate the poly(A) tail. As for nuclear polyadenylation, this complex is stabilized by Symplekin. Embryonic poly(A)-binding protein ePAB is also bound to CPEB1, and upon activation, it associates with the elongating poly(A) tail (reviewed in ref. <bibrinl rid="b52">52</bibrinl>). A similar complex with GLD-2 is assembled by other members of the CPEB family<bibr rid="b55 b56 b59"/>, and CPEB1 can recruit other canonical and noncanonical poly(A) polymerases<bibr rid="b62 b116 b117"/>.</p></bx>
<illus id="illus1" type="bmp" entname="illus1" display="print-online"></illus>
<illus id="illus2" type="bmp" entname="illus2" display="print-online"></illus>
</objects>
<audecl conflct="no"></audecl>
<bibl><bib id="b1"><reftxt><refau><snm>Di Giammartino</snm>, <fnm>D.C.</fnm></refau>, <refau><snm>Nishida</snm>, <fnm>K.</fnm></refau> &amp; <refau><snm>Manley</snm>, <fnm>J.L.</fnm></refau> <atl>Mechanisms and consequences of alternative polyadenylation</atl>. <jtl>Mol. Cell</jtl> <vid>43</vid>, <ppf>853</ppf>&ndash;<ppl>866</ppl> (<cd year="2011">2011</cd>).</reftxt></bib>
<bib id="b2"><reftxt><refau><snm>Zhang</snm>, <fnm>X.</fnm></refau>, <refau><snm>Virtanen</snm>, <fnm>A.</fnm></refau> &amp; <refau><snm>Kleiman</snm>, <fnm>F.E.</fnm></refau> <atl>To polyadenylate or to deadenylate: that is the question</atl>. <jtl>Cell Cycle</jtl> <vid>9</vid>, <ppf>4437</ppf>&ndash;<ppl>4449</ppl> (<cd year="2010">2010</cd>).</reftxt></bib>
<bib id="b3"><reftxt><refau><snm>Wells</snm>, <fnm>S.E.</fnm></refau>, <refau><snm>Hillner</snm>, <fnm>P.E.</fnm></refau>, <refau><snm>Vale</snm>, <fnm>R.D.</fnm></refau> &amp; <refau><snm>Sachs</snm>, <fnm>A.B.</fnm></refau> <atl>Circularization of mRNA by eukaryotic translation initiation factors</atl>. <jtl>Mol. Cell</jtl> <vid>2</vid>, <ppf>135</ppf>&ndash;<ppl>140</ppl> (<cd year="1998">1998</cd>).</reftxt></bib>
<bib id="b4"><reftxt><refau><snm>Kahvejian</snm>, <fnm>A.</fnm></refau>, <refau><snm>Svitkin</snm>, <fnm>Y.V.</fnm></refau>, <refau><snm>Sukarieh</snm>, <fnm>R.</fnm></refau>, <refau><snm>M&prime;Boutchou</snm>, <fnm>M.N.</fnm></refau> &amp; <refau><snm>Sonenberg</snm>, <fnm>N.</fnm></refau> <atl>Mammalian poly(A)-binding protein is a eukaryotic translation initiation factor, which acts via multiple mechanisms</atl>. <jtl>Genes Dev.</jtl> <vid>19</vid>, <ppf>104</ppf>&ndash;<ppl>113</ppl> (<cd year="2005">2005</cd>).</reftxt></bib>
<bib id="b5"><reftxt><refau><snm>Beilharz</snm>, <fnm>T.H.</fnm></refau>, <refau><snm>Humphreys</snm>, <fnm>D.T.</fnm></refau> &amp; <refau><snm>Preiss</snm>, <fnm>T.</fnm></refau> <atl>miRNA Effects on mRNA closed-loop formation during translation initiation</atl>. <jtl>Prog. Mol. Subcell. Biol.</jtl> <vid>50</vid>, <ppf>99</ppf>&ndash;<ppl>112</ppl> (<cd year="2010">2010</cd>).</reftxt></bib>
<bib id="b6"><reftxt><refau><snm>Dever</snm>, <fnm>T.E.</fnm></refau> <atl>Gene-specific regulation by general translation factors</atl>. <jtl>Cell</jtl> <vid>108</vid>, <ppf>545</ppf>&ndash;<ppl>556</ppl> (<cd year="2002">2002</cd>).</reftxt></bib>
<bib id="b7"><reftxt><refau><snm>Abaza</snm>, <fnm>I.</fnm></refau> &amp; <refau><snm>Gebauer</snm>, <fnm>F.</fnm></refau> <atl>Trading translation with RNA-binding proteins</atl>. <jtl>RNA</jtl> <vid>14</vid>, <ppf>404</ppf>&ndash;<ppl>409</ppl> (<cd year="2008">2008</cd>).</reftxt></bib>
<bib id="b8"><reftxt><refau><snm>Braun</snm>, <fnm>J.E.</fnm></refau>, <refau><snm>Huntzinger</snm>, <fnm>E.</fnm></refau>, <refau><snm>Fauser</snm>, <fnm>M.</fnm></refau> &amp; <refau><snm>Izaurralde</snm>, <fnm>E.</fnm></refau> <atl>GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets</atl>. <jtl>Mol. Cell</jtl> <vid>44</vid>, <ppf>120</ppf>&ndash;<ppl>133</ppl> (<cd year="2011">2011</cd>).</reftxt></bib>
<bib id="b9"><reftxt><refau><snm>Fabian</snm>, <fnm>M.R.</fnm></refau> <i>et al</i>. <atl>miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motifs that interact with CCR4&ndash;NOT</atl>. <jtl>Nat. Struct. Mol. Biol.</jtl> <vid>18</vid>, <ppf>1211</ppf>&ndash;<ppl>1217</ppl> (<cd year="2011">2011</cd>).</reftxt></bib>
<bib id="b10"><reftxt><refau><snm>Chekulaeva</snm>, <fnm>M.</fnm></refau> <i>et al</i>. <atl>miRNA repression involves GW182-mediated recruitment of CCR4&ndash;NOT through conserved W-containing motifs</atl>. <jtl>Nat. Struct. Mol. Biol.</jtl> <vid>18</vid>, <ppf>1218</ppf>&ndash;<ppl>1226</ppl> (<cd year="2011">2011</cd>). <newline/><b>References 8&ndash;10 show that GW182 recruits the CCR4&ndash;NOT complex through direct interaction with Not1</b>.</reftxt></bib>
<bib id="b11"><reftxt><refau><snm>Piqu&eacute;</snm>, <fnm>M.</fnm></refau>, <refau><snm>Lopez</snm>, <fnm>J.M.</fnm></refau>, <refau><snm>Foissac</snm>, <fnm>S.</fnm></refau>, <refau><snm>Guigo</snm>, <fnm>R.</fnm></refau> &amp; <refau><snm>Mendez</snm>, <fnm>R.</fnm></refau> <atl>A combinatorial code for CPE-mediated translational control</atl>. <jtl>Cell</jtl> <vid>132</vid>, <ppf>434</ppf>&ndash;<ppl>448</ppl> (<cd year="2008">2008</cd>).</reftxt></bib>
<bib id="b12"><reftxt><refau><snm>Beilharz</snm>, <fnm>T.H.</fnm></refau> &amp; <refau><snm>Preiss</snm>, <fnm>T.</fnm></refau> <atl>Widespread use of poly(A) tail length control to accentuate expression of the yeast transcriptome</atl>. <jtl>RNA</jtl> <vid>13</vid>, <ppf>982</ppf>&ndash;<ppl>997</ppl> (<cd year="2007">2007</cd>).</reftxt></bib>
<bib id="b13"><reftxt><refau><snm>Tian</snm>, <fnm>B.</fnm></refau>, <refau><snm>Hu</snm>, <fnm>J.</fnm></refau>, <refau><snm>Zhang</snm>, <fnm>H.</fnm></refau> &amp; <refau><snm>Lutz</snm>, <fnm>C.S.</fnm></refau> <atl>A large-scale analysis of mRNA polyadenylation of human and mouse genes</atl>. <jtl>Nucleic Acids Res.</jtl> <vid>33</vid>, <ppf>201</ppf>&ndash;<ppl>212</ppl> (<cd year="2005">2005</cd>).</reftxt></bib>
<bib id="b14"><reftxt><refau><snm>Sandberg</snm>, <fnm>R.</fnm></refau>, <refau><snm>Neilson</snm>, <fnm>J.R.</fnm></refau>, <refau><snm>Sarma</snm>, <fnm>A.</fnm></refau>, <refau><snm>Sharp</snm>, <fnm>P.A.</fnm></refau> &amp; <refau><snm>Burge</snm>, <fnm>C.B.</fnm></refau> <atl>Proliferating cells express mRNAs with shortened 3&prime; untranslated regions and fewer microRNA target sites</atl>. <jtl>Science</jtl> <vid>320</vid>, <ppf>1643</ppf>&ndash;<ppl>1647</ppl> (<cd year="2008">2008</cd>).</reftxt></bib>
<bib id="b15"><reftxt><refau><snm>Mayr</snm>, <fnm>C.</fnm></refau> &amp; <refau><snm>Bartel</snm>, <fnm>D.P.</fnm></refau> <atl>Widespread shortening of 3&prime;UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells</atl>. <jtl>Cell</jtl> <vid>138</vid>, <ppf>673</ppf>&ndash;<ppl>684</ppl> (<cd year="2009">2009</cd>). <newline/><b>References 14 and 15 show that proliferating and cancer cells consistently favor the use of upstream APA sites to express shortened 3&prime; UTRs, which result in increased protein expression, due in part to the exclusion of miRNA sites</b>.</reftxt></bib>
<bib id="b16"><reftxt><refau><snm>Ji</snm>, <fnm>Z.</fnm></refau>, <refau><snm>Lee</snm>, <fnm>J.Y.</fnm></refau>, <refau><snm>Pan</snm>, <fnm>Z.</fnm></refau>, <refau><snm>Jiang</snm>, <fnm>B.</fnm></refau> &amp; <refau><snm>Tian</snm>, <fnm>B.</fnm></refau> <atl>Progressive lengthening of 3&prime; untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development</atl>. <jtl>Proc. Natl. Acad. Sci. USA</jtl> <vid>106</vid>, <ppf>7028</ppf>&ndash;<ppl>7033</ppl> (<cd year="2009">2009</cd>).</reftxt></bib>
<bib id="b17"><reftxt><refau><snm>Ji</snm>, <fnm>Z.</fnm></refau> &amp; <refau><snm>Tian</snm>, <fnm>B.</fnm></refau> <atl>Reprogramming of 3&prime; untranslated regions of mRNAs by alternative polyadenylation in generation of pluripotent stem cells from different cell types</atl>. <jtl>PLoS ONE</jtl> <vid>4</vid>, <ppf>e8419</ppf> (<cd year="2009">2009</cd>).</reftxt></bib>
<bib id="b18"><reftxt><refau><snm>Mangone</snm>, <fnm>M.</fnm></refau> <i>et al</i>. <atl>The landscape of <i>C. elegans</i> 3&prime;UTRs</atl>. <jtl>Science</jtl> <vid>329</vid>, <ppf>432</ppf>&ndash;<ppl>435</ppl> (<cd year="2010">2010</cd>).</reftxt></bib>
<bib id="b19"><reftxt><refau><snm>Licatalosi</snm>, <fnm>D.D.</fnm></refau> <i>et al</i>. <atl>HITS-CLIP yields genome-wide insights into brain alternative RNA processing</atl>. <jtl>Nature</jtl> <vid>456</vid>, <ppf>464</ppf>&ndash;<ppl>469</ppl> (<cd year="2008">2008</cd>). <newline/><b>A high-throughput approach identifies a new function of Nova protein in APA site usage that favors long 3&prime;-UTR isoforms</b>.</reftxt></bib>
<bib id="b20"><reftxt><refau><snm>An</snm>, <fnm>J.J.</fnm></refau> <i>et al</i>. <atl>Distinct role of long 3&prime; UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons</atl>. <jtl>Cell</jtl> <vid>134</vid>, <ppf>175</ppf>&ndash;<ppl>187</ppl> (<cd year="2008">2008</cd>).</reftxt></bib>
<bib id="b21"><reftxt><refau><snm>Wang</snm>, <fnm>E.T.</fnm></refau> <i>et al</i>. <atl>Alternative isoform regulation in human tissue transcriptomes</atl>. <jtl>Nature</jtl> <vid>456</vid>, <ppf>470</ppf>&ndash;<ppl>476</ppl> (<cd year="2008">2008</cd>).</reftxt></bib>
<bib id="b22"><reftxt><refau><snm>Parker</snm>, <fnm>R.</fnm></refau> &amp; <refau><snm>Song</snm>, <fnm>H.</fnm></refau> <atl>The enzymes and control of eukaryotic mRNA turnover</atl>. <jtl>Nat. Struct. Mol. Biol.</jtl> <vid>11</vid>, <ppf>121</ppf>&ndash;<ppl>127</ppl> (<cd year="2004">2004</cd>).</reftxt></bib>
<bib id="b23"><reftxt><refau><snm>Mendez</snm>, <fnm>R.</fnm></refau> &amp; <refau><snm>Richter</snm>, <fnm>J.D.</fnm></refau> <atl>Translational control by CPEB: a means to the end</atl>. <jtl>Nat. Rev. Mol. Cell Biol.</jtl> <vid>2</vid>, <ppf>521</ppf>&ndash;<ppl>529</ppl> (<cd year="2001">2001</cd>).</reftxt></bib>
<bib id="b24"><reftxt><refau><snm>Goldstrohm</snm>, <fnm>A.C.</fnm></refau> &amp; <refau><snm>Wickens</snm>, <fnm>M.</fnm></refau> <atl>Multifunctional deadenylase complexes diversify mRNA control</atl>. <jtl>Nat. Rev. Mol. Cell Biol.</jtl> <vid>9</vid>, <ppf>337</ppf>&ndash;<ppl>344</ppl> (<cd year="2008">2008</cd>).</reftxt></bib>
<bib id="b25"><reftxt><refau><snm>Halees</snm>, <fnm>A.S.</fnm></refau>, <refau><snm>El-Badrawi</snm>, <fnm>R.</fnm></refau> &amp; <refau><snm>Khabar</snm>, <fnm>K.S.</fnm></refau> <atl>ARED Organism: expansion of ARED reveals AU-rich element cluster variations between human and mouse</atl>. <jtl>Nucleic Acids Res.</jtl> <vid>36</vid>, <ppf>D137</ppf>&ndash;<ppl>D140</ppl> (<cd year="2008">2008</cd>).</reftxt></bib>
<bib id="b26"><reftxt><refau><snm>Fenger-Gr&oslash;n</snm>, <fnm>M.</fnm></refau>, <refau><snm>Fillman</snm>, <fnm>C.</fnm></refau>, <refau><snm>Norrild</snm>, <fnm>B.</fnm></refau> &amp; <refau><snm>Lykke-Andersen</snm>, <fnm>J.</fnm></refau> <atl>Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping</atl>. <jtl>Mol. Cell</jtl> <vid>20</vid>, <ppf>905</ppf>&ndash;<ppl>915</ppl> (<cd year="2005">2005</cd>).</reftxt></bib>
<bib id="b27"><reftxt><refau><snm>Belloc</snm>, <fnm>E.</fnm></refau> &amp; <refau><snm>Mendez</snm>, <fnm>R.</fnm></refau> <atl>A deadenylation negative feedback mechanism governs meiotic metaphase arrest</atl>. <jtl>Nature</jtl> <vid>452</vid>, <ppf>1017</ppf>&ndash;<ppl>1021</ppl> (<cd year="2008">2008</cd>). <newline/><b>Shows how the combination of CPEs and AREs define a crucial translational circuit in meiosis</b>.</reftxt></bib>
<bib id="b28"><reftxt><refau><snm>Gherzi</snm>, <fnm>R.</fnm></refau> <i>et al</i>. <atl>A KH domain RNA binding protein, KSRP, promotes ARE-directed mRNA turnover by recruiting the degradation machinery</atl>. <jtl>Mol. Cell</jtl> <vid>14</vid>, <ppf>571</ppf>&ndash;<ppl>583</ppl> (<cd year="2004">2004</cd>).</reftxt></bib>
<bib id="b29"><reftxt><refau><snm>Peng</snm>, <fnm>S.S.</fnm></refau>, <refau><snm>Chen</snm>, <fnm>C.Y.</fnm></refau>, <refau><snm>Xu</snm>, <fnm>N.</fnm></refau> &amp; <refau><snm>Shyu</snm>, <fnm>A.B.</fnm></refau> <atl>RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein</atl>. <jtl>EMBO J.</jtl> <vid>17</vid>, <ppf>3461</ppf>&ndash;<ppl>3470</ppl> (<cd year="1998">1998</cd>).</reftxt></bib>
<bib id="b30"><reftxt><refau><snm>Kim</snm>, <fnm>J.H.</fnm></refau> &amp; <refau><snm>Richter</snm>, <fnm>J.D.</fnm></refau> <atl>Opposing polymerase-deadenylase activities regulate cytoplasmic polyadenylation</atl>. <jtl>Mol. Cell</jtl> <vid>24</vid>, <ppf>173</ppf>&ndash;<ppl>183</ppl> (<cd year="2006">2006</cd>).</reftxt></bib>
<bib id="b31"><reftxt><refau><snm>Mendez</snm>, <fnm>R.</fnm></refau> <i>et al</i>. <atl>Phosphorylation of CPE binding factor by Eg2 regulates translation of c-mos mRNA</atl>. <jtl>Nature</jtl> <vid>404</vid>, <ppf>302</ppf>&ndash;<ppl>307</ppl> (<cd year="2000">2000</cd>).</reftxt></bib>
<bib id="b32"><reftxt><refau><snm>Mendez</snm>, <fnm>R.</fnm></refau>, <refau><snm>Murthy</snm>, <fnm>K.G.</fnm></refau>, <refau><snm>Ryan</snm>, <fnm>K.</fnm></refau>, <refau><snm>Manley</snm>, <fnm>J.L.</fnm></refau> &amp; <refau><snm>Richter</snm>, <fnm>J.D.</fnm></refau> <atl>Phosphorylation of CPEB by Eg2 mediates the recruitment of CPSF into an active cytoplasmic polyadenylation complex</atl>. <jtl>Mol. Cell</jtl> <vid>6</vid>, <ppf>1253</ppf>&ndash;<ppl>1259</ppl> (<cd year="2000">2000</cd>).</reftxt></bib>
<bib id="b33"><reftxt><refau><snm>Minshall</snm>, <fnm>N.</fnm></refau>, <refau><snm>Reiter</snm>, <fnm>M.H.</fnm></refau>, <refau><snm>Weil</snm>, <fnm>D.</fnm></refau> &amp; <refau><snm>Standart</snm>, <fnm>N.</fnm></refau> <atl>CPEB interacts with an ovary-specific eIF4E and 4E-T in early <i>Xenopus</i> oocytes</atl>. <jtl>J. Biol. Chem.</jtl> <vid>282</vid>, <ppf>37389</ppf>&ndash;<ppl>37401</ppl> (<cd year="2007">2007</cd>).</reftxt></bib>
<bib id="b34"><reftxt><refau><snm>Igreja</snm>, <fnm>C.</fnm></refau> &amp; <refau><snm>Izaurralde</snm>, <fnm>E.</fnm></refau> <atl>CUP promotes deadenylation and inhibits decapping of mRNA targets</atl>. <jtl>Genes Dev.</jtl> <vid>25</vid>, <ppf>1955</ppf>&ndash;<ppl>1967</ppl> (<cd year="2011">2011</cd>).</reftxt></bib>
<bib id="b35"><reftxt><refau><snm>Hosoda</snm>, <fnm>N.</fnm></refau> <i>et al</i>. <atl>Anti-proliferative protein Tob negatively regulates CPEB3 target by recruiting Caf1 deadenylase</atl>. <jtl>EMBO J.</jtl> <vid>30</vid>, <ppf>1311</ppf>&ndash;<ppl>1323</ppl> (<cd year="2011">2011</cd>).</reftxt></bib>
<bib id="b36"><reftxt><refau><snm>Gerber</snm>, <fnm>A.P.</fnm></refau>, <refau><snm>Herschlag</snm>, <fnm>D.</fnm></refau> &amp; <refau><snm>Brown</snm>, <fnm>P.O.</fnm></refau> <atl>Extensive association of functionally and cytotopically related mRNAs with Puf family RNA-binding proteins in yeast</atl>. <jtl>PLoS Biol.</jtl> <vid>2</vid>, <ppf>E79</ppf> (<cd year="2004">2004</cd>).</reftxt></bib>
<bib id="b37"><reftxt><refau><snm>Goldstrohm</snm>, <fnm>A.C.</fnm></refau>, <refau><snm>Hook</snm>, <fnm>B.A.</fnm></refau>, <refau><snm>Seay</snm>, <fnm>D.J.</fnm></refau> &amp; <refau><snm>Wickens</snm>, <fnm>M.</fnm></refau> <atl>PUF proteins bind Pop2p to regulate messenger RNAs</atl>. <jtl>Nat. Struct. Mol. Biol.</jtl> <vid>13</vid>, <ppf>533</ppf>&ndash;<ppl>539</ppl> (<cd year="2006">2006</cd>).</reftxt></bib>
<bib id="b38"><reftxt><refau><snm>Kadyrova</snm>, <fnm>L.Y.</fnm></refau>, <refau><snm>Habara</snm>, <fnm>Y.</fnm></refau>, <refau><snm>Lee</snm>, <fnm>T.H.</fnm></refau> &amp; <refau><snm>Wharton</snm>, <fnm>R.P.</fnm></refau> <atl>Translational control of maternal <i>Cyclin B</i> mRNA by Nanos in the <i>Drosophila</i> germline</atl>. <jtl>Development</jtl> <vid>134</vid>, <ppf>1519</ppf>&ndash;<ppl>1527</ppl> (<cd year="2007">2007</cd>).</reftxt></bib>
<bib id="b39"><reftxt><refau><snm>Ota</snm>, <fnm>R.</fnm></refau>, <refau><snm>Kotani</snm>, <fnm>T.</fnm></refau> &amp; <refau><snm>Yamashita</snm>, <fnm>M.</fnm></refau> <atl>Biochemical characterization of Pumilio1 and Pumilio2 in <i>Xenopus</i> oocytes</atl>. <jtl>J. Biol. Chem.</jtl> <vid>286</vid>, <ppf>2853</ppf>&ndash;<ppl>2863</ppl> (<cd year="2011">2011</cd>).</reftxt></bib>
<bib id="b40"><reftxt><refau><snm>Graindorge</snm>, <fnm>A.</fnm></refau> <i>et al</i>. <atl>Identification of CUG-BP1/EDEN-BP target mRNAs in <i>Xenopus tropicalis</i></atl>. <jtl>Nucleic Acids Res.</jtl> <vid>36</vid>, <ppf>1861</ppf>&ndash;<ppl>1870</ppl> (<cd year="2008">2008</cd>).</reftxt></bib>
<bib id="b41"><reftxt><refau><snm>Moraes</snm>, <fnm>K.C.</fnm></refau>, <refau><snm>Wilusz</snm>, <fnm>C.J.</fnm></refau> &amp; <refau><snm>Wilusz</snm>, <fnm>J.</fnm></refau> <atl>CUG-BP binds to RNA substrates and recruits PARN deadenylase</atl>. <jtl>RNA</jtl> <vid>12</vid>, <ppf>1084</ppf>&ndash;<ppl>1091</ppl> (<cd year="2006">2006</cd>).</reftxt></bib>
<bib id="b42"><reftxt><refau><snm>Fabian</snm>, <fnm>M.R.</fnm></refau> &amp; <refau><snm>Sonenberg</snm>, <fnm>N.</fnm></refau> <atl>The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC</atl>. <jtl>Nat. Struct. Mol. Biol.</jtl> <vid>19</vid>, <ppf>586</ppf>&ndash;<ppl>593</ppl> (<cd year="2012">2012</cd>).</reftxt></bib>
<bib id="b43"><reftxt><refau><snm>Fabian</snm>, <fnm>M.R.</fnm></refau> <i>et al</i>. <atl>Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation</atl>. <jtl>Mol. Cell</jtl> <vid>35</vid>, <ppf>868</ppf>&ndash;<ppl>880</ppl> (<cd year="2009">2009</cd>).</reftxt></bib>
<bib id="b44"><reftxt><refau><snm>Bazzini</snm>, <fnm>A.A.</fnm></refau>, <refau><snm>Lee</snm>, <fnm>M.T.</fnm></refau> &amp; <refau><snm>Giraldez</snm>, <fnm>A.J.</fnm></refau> <atl>Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish</atl>. <jtl>Science</jtl> <vid>336</vid>, <ppf>233</ppf>&ndash;<ppl>237</ppl> (<cd year="2012">2012</cd>).</reftxt></bib>
<bib id="b45"><reftxt><refau><snm>Djuranovic</snm>, <fnm>S.</fnm></refau>, <refau><snm>Nahvi</snm>, <fnm>A.</fnm></refau> &amp; <refau><snm>Green</snm>, <fnm>R.</fnm></refau> <atl>miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay</atl>. <jtl>Science</jtl> <vid>336</vid>, <ppf>237</ppf>&ndash;<ppl>240</ppl> (<cd year="2012">2012</cd>). <newline/><b>References 44 and 45 show for the first time how a miRNA affects ribosome occupancy prior to deadenylation</b>.</reftxt></bib>
<bib id="b46"><reftxt><refau><snm>Jing</snm>, <fnm>Q.</fnm></refau> <i>et al</i>. <atl>Involvement of microRNA in AU-rich element-mediated mRNA instability</atl>. <jtl>Cell</jtl> <vid>120</vid>, <ppf>623</ppf>&ndash;<ppl>634</ppl> (<cd year="2005">2005</cd>).</reftxt></bib>
<bib id="b47"><reftxt><refau><snm>Kim</snm>, <fnm>H.H.</fnm></refau> <i>et al</i>. <atl>HuR recruits let-7/RISC to repress c-Myc expression</atl>. <jtl>Genes Dev.</jtl> <vid>23</vid>, <ppf>1743</ppf>&ndash;<ppl>1748</ppl> (<cd year="2009">2009</cd>).</reftxt></bib>
<bib id="b48"><reftxt><refau><snm>Bhattacharyya</snm>, <fnm>S.N.</fnm></refau>, <refau><snm>Habermacher</snm>, <fnm>R.</fnm></refau>, <refau><snm>Martine</snm>, <fnm>U.</fnm></refau>, <refau><snm>Closs</snm>, <fnm>E.I.</fnm></refau> &amp; <refau><snm>Filipowicz</snm>, <fnm>W.</fnm></refau> <atl>Relief of microRNA-mediated translational repression in human cells subjected to stress</atl>. <jtl>Cell</jtl> <vid>125</vid>, <ppf>1111</ppf>&ndash;<ppl>1124</ppl> (<cd year="2006">2006</cd>).</reftxt></bib>
<bib id="b49"><reftxt><refau><snm>Asirvatham</snm>, <fnm>A.J.</fnm></refau>, <refau><snm>Gregorie</snm>, <fnm>C.J.</fnm></refau>, <refau><snm>Hu</snm>, <fnm>Z.</fnm></refau>, <refau><snm>Magner</snm>, <fnm>W.J.</fnm></refau> &amp; <refau><snm>Tomasi</snm>, <fnm>T.B.</fnm></refau> <atl>MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components</atl>. <jtl>Mol. Immunol.</jtl> <vid>45</vid>, <ppf>1995</ppf>&ndash;<ppl>2006</ppl> (<cd year="2008">2008</cd>).</reftxt></bib>
<bib id="b50"><reftxt><refau><snm>Collier</snm>, <fnm>B.</fnm></refau>, <refau><snm>Gorgoni</snm>, <fnm>B.</fnm></refau>, <refau><snm>Loveridge</snm>, <fnm>C.</fnm></refau>, <refau><snm>Cooke</snm>, <fnm>H.J.</fnm></refau> &amp; <refau><snm>Gray</snm>, <fnm>N.K.</fnm></refau> <atl>The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells</atl>. <jtl>EMBO J.</jtl> <vid>24</vid>, <ppf>2656</ppf>&ndash;<ppl>2666</ppl> (<cd year="2005">2005</cd>).</reftxt></bib>
<bib id="b51"><reftxt><refau><snm>Cakmakci</snm>, <fnm>N.G.</fnm></refau>, <refau><snm>Lerner</snm>, <fnm>R.S.</fnm></refau>, <refau><snm>Wagner</snm>, <fnm>E.J.</fnm></refau>, <refau><snm>Zheng</snm>, <fnm>L.</fnm></refau> &amp; <refau><snm>Marzluff</snm>, <fnm>W.F.</fnm></refau> <atl>SLIP1, a factor required for activation of histone mRNA translation by the stem-loop binding protein</atl>. <jtl>Mol. Cell. Biol.</jtl> <vid>28</vid>, <ppf>1182</ppf>&ndash;<ppl>1194</ppl> (<cd year="2008">2008</cd>).</reftxt></bib>
<bib id="b52"><reftxt><refau><snm>Richter</snm>, <fnm>J.D.</fnm></refau> <atl>CPEB: a life in translation</atl>. <jtl>Trends Biochem. Sci.</jtl> <vid>32</vid>, <ppf>279</ppf>&ndash;<ppl>285</ppl> (<cd year="2007">2007</cd>).</reftxt></bib>
<bib id="b53"><reftxt><refau><snm>Theis</snm>, <fnm>M.</fnm></refau>, <refau><snm>Si</snm>, <fnm>K.</fnm></refau> &amp; <refau><snm>Kandel</snm>, <fnm>E.R.</fnm></refau> <atl>Two previously undescribed members of the mouse CPEB family of genes and their inducible expression in the principal cell layers of the hippocampus</atl>. <jtl>Proc. Natl. Acad. Sci. USA</jtl> <vid>100</vid>, <ppf>9602</ppf>&ndash;<ppl>9607</ppl> (<cd year="2003">2003</cd>).</reftxt></bib>
<bib id="b54"><reftxt><refau><snm>Wang</snm>, <fnm>X.P.</fnm></refau> &amp; <refau><snm>Cooper</snm>, <fnm>N.G.</fnm></refau> <atl>Comparative <i>in silico</i> analyses of cpeb1&ndash;4 with functional predictions</atl>. <jtl>Bioinform. Biol. Insights</jtl> <vid>4</vid>, <ppf>61</ppf>&ndash;<ppl>83</ppl> (<cd year="2010">2010</cd>).</reftxt></bib>
<bib id="b55"><reftxt><refau><snm>Novoa</snm>, <fnm>I.</fnm></refau>, <refau><snm>Gallego</snm>, <fnm>J.</fnm></refau>, <refau><snm>Ferreira</snm>, <fnm>P.G.</fnm></refau> &amp; <refau><snm>Mendez</snm>, <fnm>R.</fnm></refau> <atl>Mitotic cell-cycle progression is regulated by CPEB1 and CPEB4-dependent translational control</atl>. <jtl>Nat. Cell Biol.</jtl> <vid>12</vid>, <ppf>447</ppf>&ndash;<ppl>456</ppl> (<cd year="2010">2010</cd>).</reftxt></bib>
<bib id="b56"><reftxt><refau><snm>Igea</snm>, <fnm>A.</fnm></refau> &amp; <refau><snm>Mendez</snm>, <fnm>R.</fnm></refau> <atl>Meiosis requires a translational positive loop where CPEB1 ensues its replacement by CPEB4</atl>. <jtl>EMBO J.</jtl> <vid>29</vid>, <ppf>2182</ppf>&ndash;<ppl>2193</ppl> (<cd year="2010">2010</cd>).</reftxt></bib>
<bib id="b57"><reftxt><refau><snm>Huang</snm>, <fnm>Y.S.</fnm></refau>, <refau><snm>Kan</snm>, <fnm>M.C.</fnm></refau>, <refau><snm>Lin</snm>, <fnm>C.L.</fnm></refau> &amp; <refau><snm>Richter</snm>, <fnm>J.D.</fnm></refau> <atl>CPEB3 and CPEB4 in neurons: analysis of RNA-binding specificity and translational control of AMPA receptor GluR2 mRNA</atl>. <jtl>EMBO J.</jtl> <vid>25</vid>, <ppf>4865</ppf>&ndash;<ppl>4876</ppl> (<cd year="2006">2006</cd>).</reftxt></bib>
<bib id="b58"><reftxt><refau><snm>Ortiz-Zapater</snm>, <fnm>E.</fnm></refau> <i>et al</i>. <atl>Key contribution of CPEB4-mediated translational control to cancer progression</atl>. <jtl>Nat. Med.</jtl> <vid>18</vid>, <ppf>83</ppf>&ndash;<ppl>90</ppl> (<cd year="2012">2012</cd>).</reftxt></bib>
<bib id="b59"><reftxt><refau><snm>Pavlopoulos</snm>, <fnm>E.</fnm></refau> <i>et al</i>. <atl>Neuralized1 activates CPEB3: a function for nonproteolytic ubiquitin in synaptic plasticity and memory storage</atl>. <jtl>Cell</jtl> <vid>147</vid>, <ppf>1369</ppf>&ndash;<ppl>1383</ppl> (<cd year="2011">2011</cd>).</reftxt></bib>
<bib id="b60"><reftxt><refau><snm>Huang</snm>, <fnm>Y.S.</fnm></refau>, <refau><snm>Jung</snm>, <fnm>M.Y.</fnm></refau>, <refau><snm>Sarkissian</snm>, <fnm>M.</fnm></refau> &amp; <refau><snm>Richter</snm>, <fnm>J.D.</fnm></refau> <atl><i>N</i>-methyl-d-aspartate receptor signaling results in Aurora kinase-catalyzed CPEB phosphorylation and &alpha;CaMKII mRNA polyadenylation at synapses</atl>. <jtl>EMBO J.</jtl> <vid>21</vid>, <ppf>2139</ppf>&ndash;<ppl>2148</ppl> (<cd year="2002">2002</cd>).</reftxt></bib>
<bib id="b61"><reftxt><refau><snm>Atkins</snm>, <fnm>C.M.</fnm></refau>, <refau><snm>Nozaki</snm>, <fnm>N.</fnm></refau>, <refau><snm>Shigeri</snm>, <fnm>Y.</fnm></refau> &amp; <refau><snm>Soderling</snm>, <fnm>T.R.</fnm></refau> <atl>Cytoplasmic polyadenylation element binding protein-dependent protein synthesis is regulated by calcium/calmodulin-dependent protein kinase II</atl>. <jtl>J. Neurosci.</jtl> <vid>24</vid>, <ppf>5193</ppf>&ndash;<ppl>5201</ppl> (<cd year="2004">2004</cd>).</reftxt></bib>
<bib id="b62"><reftxt><refau><snm>Burns</snm>, <fnm>D.M.</fnm></refau>, <refau><snm>D&prime;Ambrogio</snm>, <fnm>A.</fnm></refau>, <refau><snm>Nottrott</snm>, <fnm>S.</fnm></refau> &amp; <refau><snm>Richter</snm>, <fnm>J.D.</fnm></refau> <atl>CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation</atl>. <jtl>Nature</jtl> <vid>473</vid>, <ppf>105</ppf>&ndash;<ppl>108</ppl> (<cd year="2011">2011</cd>).</reftxt></bib>
<bib id="b63"><reftxt><refau><snm>Charlesworth</snm>, <fnm>A.</fnm></refau>, <refau><snm>Cox</snm>, <fnm>L.L.</fnm></refau> &amp; <refau><snm>MacNicol</snm>, <fnm>A.M.</fnm></refau> <atl>Cytoplasmic polyadenylation element (CPE)- and CPE-binding protein (CPEB)-independent mechanisms regulate early class maternal mRNA translational activation in <i>Xenopus</i> oocytes</atl>. <jtl>J. Biol. Chem.</jtl> <vid>279</vid>, <ppf>17650</ppf>&ndash;<ppl>17659</ppl> (<cd year="2004">2004</cd>).</reftxt></bib>
<bib id="b64"><reftxt><refau><snm>Coll</snm>, <fnm>O.</fnm></refau>, <refau><snm>Villalba</snm>, <fnm>A.</fnm></refau>, <refau><snm>Bussotti</snm>, <fnm>G.</fnm></refau>, <refau><snm>Notredame</snm>, <fnm>C.</fnm></refau> &amp; <refau><snm>Gebauer</snm>, <fnm>F.</fnm></refau> <atl>A novel, noncanonical mechanism of cytoplasmic polyadenylation operates in <i>Drosophila</i> embryogenesis</atl>. <jtl>Genes Dev.</jtl> <vid>24</vid>, <ppf>129</ppf>&ndash;<ppl>134</ppl> (<cd year="2010">2010</cd>).</reftxt></bib>
<bib id="b65"><reftxt><refau><snm>Mazumder</snm>, <fnm>B.</fnm></refau>, <refau><snm>Li</snm>, <fnm>X.</fnm></refau> &amp; <refau><snm>Barik</snm>, <fnm>S.</fnm></refau> <atl>Translation control: a multifaceted regulator of inflammatory response</atl>. <jtl>J. Immunol.</jtl> <vid>184</vid>, <ppf>3311</ppf>&ndash;<ppl>3319</ppl> (<cd year="2010">2010</cd>).</reftxt></bib>
<bib id="b66"><reftxt><refau><snm>Kontoyiannis</snm>, <fnm>D.</fnm></refau>, <refau><snm>Pasparakis</snm>, <fnm>M.</fnm></refau>, <refau><snm>Pizarro</snm>, <fnm>T.T.</fnm></refau>, <refau><snm>Cominelli</snm>, <fnm>F.</fnm></refau> &amp; <refau><snm>Kollias</snm>, <fnm>G.</fnm></refau> <atl>Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies</atl>. <jtl>Immunity</jtl> <vid>10</vid>, <ppf>387</ppf>&ndash;<ppl>398</ppl> (<cd year="1999">1999</cd>).</reftxt></bib>
<bib id="b67"><reftxt><refau><snm>Carballo</snm>, <fnm>E.</fnm></refau>, <refau><snm>Lai</snm>, <fnm>W.S.</fnm></refau> &amp; <refau><snm>Blackshear</snm>, <fnm>P.J.</fnm></refau> <atl>Feedback inhibition of macrophage tumor necrosis factor-&alpha; production by tristetraprolin</atl>. <jtl>Science</jtl> <vid>281</vid>, <ppf>1001</ppf>&ndash;<ppl>1005</ppl> (<cd year="1998">1998</cd>).</reftxt></bib>
<bib id="b68"><reftxt><refau><snm>Marchese</snm>, <fnm>F.P.</fnm></refau> <i>et al</i>. <atl>MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment</atl>. <jtl>J. Biol. Chem.</jtl> <vid>285</vid>, <ppf>27590</ppf>&ndash;<ppl>27600</ppl> (<cd year="2010">2010</cd>).</reftxt></bib>
<bib id="b69"><reftxt><refau><snm>Katsanou</snm>, <fnm>V.</fnm></refau> <i>et al</i>. <atl>HuR as a negative posttranscriptional modulator in inflammation</atl>. <jtl>Mol. Cell</jtl> <vid>19</vid>, <ppf>777</ppf>&ndash;<ppl>789</ppl> (<cd year="2005">2005</cd>).</reftxt></bib>
<bib id="b70"><reftxt><refau><snm>Tili</snm>, <fnm>E.</fnm></refau> <i>et al</i>. <atl>Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-&alpha; stimulation and their possible roles in regulating the response to endotoxin shock</atl>. <jtl>J. Immunol.</jtl> <vid>179</vid>, <ppf>5082</ppf>&ndash;<ppl>5089</ppl> (<cd year="2007">2007</cd>).</reftxt></bib>
<bib id="b71"><reftxt><refau><snm>Mukhopadhyay</snm>, <fnm>D.</fnm></refau>, <refau><snm>Houchen</snm>, <fnm>C.W.</fnm></refau>, <refau><snm>Kennedy</snm>, <fnm>S.</fnm></refau>, <refau><snm>Dieckgraefe</snm>, <fnm>B.K.</fnm></refau> &amp; <refau><snm>Anant</snm>, <fnm>S.</fnm></refau> <atl>Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2</atl>. <jtl>Mol. Cell</jtl> <vid>11</vid>, <ppf>113</ppf>&ndash;<ppl>126</ppl> (<cd year="2003">2003</cd>). <newline/><b>Shows that CUGBP2 binding inhibits Cox-2 translation and stabilizes the mRNA</b>.</reftxt></bib>
<bib id="b72"><reftxt><refau><snm>Young</snm>, <fnm>L.E.</fnm></refau>, <refau><snm>Moore</snm>, <fnm>A.E.</fnm></refau>, <refau><snm>Sokol</snm>, <fnm>L.</fnm></refau>, <refau><snm>Meisner-Kober</snm>, <fnm>N.</fnm></refau> &amp; <refau><snm>Dixon</snm>, <fnm>D.A.</fnm></refau> <atl>The mRNA stability factor HuR inhibits MicroRNA-16 targeting of COX-2</atl>. <jtl>Mol. Cancer Res.</jtl> <vid>10</vid>, <ppf>167</ppf>&ndash;<ppl>180</ppl> (<cd year="2012">2012</cd>).</reftxt></bib>
<bib id="b73"><reftxt><refau><snm>Xu</snm>, <fnm>F.</fnm></refau> <i>et al</i>. <atl>Loss of repression of HuR translation by miR-16 may be responsible for the elevation of HuR in human breast carcinoma</atl>. <jtl>J. Cell. Biochem.</jtl> <vid>111</vid>, <ppf>727</ppf>&ndash;<ppl>734</ppl> (<cd year="2010">2010</cd>).</reftxt></bib>
<bib id="b74"><reftxt><refau><snm>Chuvpilo</snm>, <fnm>S.</fnm></refau> <i>et al</i>. <atl>Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells</atl>. <jtl>Immunity</jtl> <vid>10</vid>, <ppf>261</ppf>&ndash;<ppl>269</ppl> (<cd year="1999">1999</cd>).</reftxt></bib>
<bib id="b75"><reftxt><refau><snm>Shell</snm>, <fnm>S.A.</fnm></refau>, <refau><snm>Hesse</snm>, <fnm>C.</fnm></refau>, <refau><snm>Morris</snm>, <fnm>S.M.</fnm> <suff>Jr.</suff></refau> &amp; <refau><snm>Milcarek</snm>, <fnm>C.</fnm></refau> <atl>Elevated levels of the 64-kDa cleavage stimulatory factor (CstF-64) in lipopolysaccharide-stimulated macrophages influence gene expression and induce alternative poly(A) site selection</atl>. <jtl>J. Biol. Chem.</jtl> <vid>280</vid>, <ppf>39950</ppf>&ndash;<ppl>39961</ppl> (<cd year="2005">2005</cd>).</reftxt></bib>
<bib id="b76"><reftxt><refau><snm>Hall-Pogar</snm>, <fnm>T.</fnm></refau>, <refau><snm>Zhang</snm>, <fnm>H.</fnm></refau>, <refau><snm>Tian</snm>, <fnm>B.</fnm></refau> &amp; <refau><snm>Lutz</snm>, <fnm>C.S.</fnm></refau> <atl>Alternative polyadenylation of cyclooxygenase-2</atl>. <jtl>Nucleic Acids Res.</jtl> <vid>33</vid>, <ppf>2565</ppf>&ndash;<ppl>2579</ppl> (<cd year="2005">2005</cd>).</reftxt></bib>
<bib id="b77"><reftxt><refau><snm>Groppo</snm>, <fnm>R.</fnm></refau> &amp; <refau><snm>Richter</snm>, <fnm>J.D.</fnm></refau> <atl>CPEB control of NF-&kappa;B nuclear localization and IL-6 production mediates cellular senescence</atl>. <jtl>Mol. Cell. Biol.</jtl> <vid>31</vid>, <ppf>2707</ppf>&ndash;<ppl>2714</ppl> (<cd year="2011">2011</cd>).</reftxt></bib>
<bib id="b78"><reftxt><refau><snm>Burns</snm>, <fnm>D.M.</fnm></refau> &amp; <refau><snm>Richter</snm>, <fnm>J.D.</fnm></refau> <atl>CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation</atl>. <jtl>Genes Dev.</jtl> <vid>22</vid>, <ppf>3449</ppf>&ndash;<ppl>3460</ppl> (<cd year="2008">2008</cd>).</reftxt></bib>
<bib id="b79"><reftxt><refau><snm>Costa-Mattioli</snm>, <fnm>M.</fnm></refau>, <refau><snm>Sossin</snm>, <fnm>W.S.</fnm></refau>, <refau><snm>Klann</snm>, <fnm>E.</fnm></refau> &amp; <refau><snm>Sonenberg</snm>, <fnm>N.</fnm></refau> <atl>Translational control of long-lasting synaptic plasticity and memory</atl>. <jtl>Neuron</jtl> <vid>61</vid>, <ppf>10</ppf>&ndash;<ppl>26</ppl> (<cd year="2009">2009</cd>).</reftxt></bib>
<bib id="b80"><reftxt><refau><snm>Wu</snm>, <fnm>L.</fnm></refau> <i>et al</i>. <atl>CPEB-mediated cytoplasmic polyadenylation and the regulation of experience-dependent translation of &alpha;-CaMKII mRNA at synapses</atl>. <jtl>Neuron</jtl> <vid>21</vid>, <ppf>1129</ppf>&ndash;<ppl>1139</ppl> (<cd year="1998">1998</cd>). <newline/><b>Shows that CPEB is present in brain and regulates &alpha;CaMKII mRNA polyadenylation</b>.</reftxt></bib>
<bib id="b81"><reftxt><refau><snm>Huang</snm>, <fnm>Y.S.</fnm></refau>, <refau><snm>Carson</snm>, <fnm>J.H.</fnm></refau>, <refau><snm>Barbarese</snm>, <fnm>E.</fnm></refau> &amp; <refau><snm>Richter</snm>, <fnm>J.D.</fnm></refau> <atl>Facilitation of dendritic mRNA transport by CPEB</atl>. <jtl>Genes Dev.</jtl> <vid>17</vid>, <ppf>638</ppf>&ndash;<ppl>653</ppl> (<cd year="2003">2003</cd>).</reftxt></bib>
<bib id="b82"><reftxt><refau><snm>Alarcon</snm>, <fnm>J.M.</fnm></refau> <i>et al</i>. <atl>Selective modulation of some forms of Schaffer collateral-CA1 synaptic plasticity in mice with a disruption of the <i>CPEB-1</i> gene</atl>. <jtl>Learn. Mem.</jtl> <vid>11</vid>, <ppf>318</ppf>&ndash;<ppl>327</ppl> (<cd year="2004">2004</cd>).</reftxt></bib>
<bib id="b83"><reftxt><refau><snm>Berger-Sweeney</snm>, <fnm>J.</fnm></refau>, <refau><snm>Zearfoss</snm>, <fnm>N.R.</fnm></refau> &amp; <refau><snm>Richter</snm>, <fnm>J.D.</fnm></refau> <atl>Reduced extinction of hippocampal-dependent memories in CPEB knockout mice</atl>. <jtl>Learn. Mem.</jtl> <vid>13</vid>, <ppf>4</ppf>&ndash;<ppl>7</ppl> (<cd year="2006">2006</cd>).</reftxt></bib>
<bib id="b84"><reftxt><refau><snm>Atkins</snm>, <fnm>C.M.</fnm></refau>, <refau><snm>Davare</snm>, <fnm>M.A.</fnm></refau>, <refau><snm>Oh</snm>, <fnm>M.C.</fnm></refau>, <refau><snm>Derkach</snm>, <fnm>V.</fnm></refau> &amp; <refau><snm>Soderling</snm>, <fnm>T.R.</fnm></refau> <atl>Bidirectional regulation of cytoplasmic polyadenylation element-binding protein phosphorylation by Ca<super>2+</super>/calmodulin-dependent protein kinase II and protein phosphatase 1 during hippocampal long-term potentiation</atl>. <jtl>J. Neurosci.</jtl> <vid>25</vid>, <ppf>5604</ppf>&ndash;<ppl>5610</ppl> (<cd year="2005">2005</cd>).</reftxt></bib>
<bib id="b85"><reftxt><refau><snm>Aslam</snm>, <fnm>N.</fnm></refau>, <refau><snm>Kubota</snm>, <fnm>Y.</fnm></refau>, <refau><snm>Wells</snm>, <fnm>D.</fnm></refau> &amp; <refau><snm>Shouval</snm>, <fnm>H.Z.</fnm></refau> <atl>Translational switch for long-term maintenance of synaptic plasticity</atl>. <jtl>Mol. Syst. Biol.</jtl> <vid>5</vid>, <ppf>284</ppf> (<cd year="2009">2009</cd>).</reftxt></bib>
<bib id="b86"><reftxt><refau><snm>Miller</snm>, <fnm>S.</fnm></refau> <i>et al</i>. <atl>Disruption of dendritic translation of CaMKII&alpha; impairs stabilization of synaptic plasticity and memory consolidation</atl>. <jtl>Neuron</jtl> <vid>36</vid>, <ppf>507</ppf>&ndash;<ppl>519</ppl> (<cd year="2002">2002</cd>). <newline/><b>Describes how memory requires &alpha;CaMKII local translation driven by its 3&prime; UTR</b>.</reftxt></bib>
<bib id="b87"><reftxt><refau><snm>Zearfoss</snm>, <fnm>N.R.</fnm></refau>, <refau><snm>Alarcon</snm>, <fnm>J.M.</fnm></refau>, <refau><snm>Trifilieff</snm>, <fnm>P.</fnm></refau>, <refau><snm>Kandel</snm>, <fnm>E.</fnm></refau> &amp; <refau><snm>Richter</snm>, <fnm>J.D.</fnm></refau> <atl>A molecular circuit composed of CPEB-1 and c-Jun controls growth hormone-mediated synaptic plasticity in the mouse hippocampus</atl>. <jtl>J. Neurosci.</jtl> <vid>28</vid>, <ppf>8502</ppf>&ndash;<ppl>8509</ppl> (<cd year="2008">2008</cd>).</reftxt></bib>
<bib id="b88"><reftxt><refau><snm>Shin</snm>, <fnm>C.Y.</fnm></refau>, <refau><snm>Kundel</snm>, <fnm>M.</fnm></refau> &amp; <refau><snm>Wells</snm>, <fnm>D.G.</fnm></refau> <atl>Rapid, activity-induced increase in tissue plasminogen activator is mediated by metabotropic glutamate receptor-dependent mRNA translation</atl>. <jtl>J. Neurosci.</jtl> <vid>24</vid>, <ppf>9425</ppf>&ndash;<ppl>9433</ppl> (<cd year="2004">2004</cd>).</reftxt></bib>
<bib id="b89"><reftxt><refau><snm>Oe</snm>, <fnm>S.</fnm></refau> &amp; <refau><snm>Yoneda</snm>, <fnm>Y.</fnm></refau> <atl>Cytoplasmic polyadenylation element-like sequences are involved in dendritic targeting of BDNF mRNA in hippocampal neurons</atl>. <jtl>FEBS Lett.</jtl> <vid>584</vid>, <ppf>3424</ppf>&ndash;<ppl>3430</ppl> (<cd year="2010">2010</cd>).</reftxt></bib>
<bib id="b90"><reftxt><refau><snm>Si</snm>, <fnm>K.</fnm></refau>, <refau><snm>Choi</snm>, <fnm>Y.B.</fnm></refau>, <refau><snm>White-Grindley</snm>, <fnm>E.</fnm></refau>, <refau><snm>Majumdar</snm>, <fnm>A.</fnm></refau> &amp; <refau><snm>Kandel</snm>, <fnm>E.R.</fnm></refau> <atl>Aplysia CPEB can form prion-like multimers in sensory neurons that contribute to long-term facilitation</atl>. <jtl>Cell</jtl> <vid>140</vid>, <ppf>421</ppf>&ndash;<ppl>435</ppl> (<cd year="2010">2010</cd>).</reftxt></bib>
<bib id="b91"><reftxt><refau><snm>Keleman</snm>, <fnm>K.</fnm></refau>, <refau><snm>Kruttner</snm>, <fnm>S.</fnm></refau>, <refau><snm>Alenius</snm>, <fnm>M.</fnm></refau> &amp; <refau><snm>Dickson</snm>, <fnm>B.J.</fnm></refau> <atl>Function of the <i>Drosophila</i> CPEB protein Orb2 in long-term courtship memory</atl>. <jtl>Nat. Neurosci.</jtl> <vid>10</vid>, <ppf>1587</ppf>&ndash;<ppl>1593</ppl> (<cd year="2007">2007</cd>).</reftxt></bib>
<bib id="b92"><reftxt><refau><snm>Majumdar</snm>, <fnm>A.</fnm></refau> <i>et al</i>. <atl>Critical role of amyloid-like oligomers of <i>Drosophila</i> Orb2 in the persistence of memory</atl>. <jtl>Cell</jtl> <vid>148</vid>, <ppf>515</ppf>&ndash;<ppl>529</ppl> (<cd year="2012">2012</cd>). <newline/><b>References 91 and 92 show that the Q-rich region of Orb2 is responsible for its oligomerization and prion-like features and is furthermore essential for fly behavior</b>.</reftxt></bib>
<bib id="b93"><reftxt><refau><snm>Mastushita-Sakai</snm>, <fnm>T.</fnm></refau>, <refau><snm>White-Grindley</snm>, <fnm>E.</fnm></refau>, <refau><snm>Samuelson</snm>, <fnm>J.</fnm></refau>, <refau><snm>Seidel</snm>, <fnm>C.</fnm></refau> &amp; <refau><snm>Si</snm>, <fnm>K.</fnm></refau> <atl><i>Drosophila</i> Orb2 targets genes involved in neuronal growth, synapse formation, and protein turnover</atl>. <jtl>Proc. Natl. Acad. Sci. USA</jtl> <vid>107</vid>, <ppf>11987</ppf>&ndash;<ppl>11992</ppl> (<cd year="2010">2010</cd>).</reftxt></bib>
<bib id="b94"><reftxt><refau><snm>Ashraf</snm>, <fnm>S.I.</fnm></refau>, <refau><snm>McLoon</snm>, <fnm>A.L.</fnm></refau>, <refau><snm>Sclarsic</snm>, <fnm>S.M.</fnm></refau> &amp; <refau><snm>Kunes</snm>, <fnm>S.</fnm></refau> <atl>Synaptic protein synthesis associated with memory is regulated by the RISC pathway in <i>Drosophila</i></atl>. <jtl>Cell</jtl> <vid>124</vid>, <ppf>191</ppf>&ndash;<ppl>205</ppl> (<cd year="2006">2006</cd>).</reftxt></bib>
<bib id="b95"><reftxt><refau><snm>Flavell</snm>, <fnm>S.W.</fnm></refau> <i>et al</i>. <atl>Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection</atl>. <jtl>Neuron</jtl> <vid>60</vid>, <ppf>1022</ppf>&ndash;<ppl>1038</ppl> (<cd year="2008">2008</cd>).</reftxt></bib>
<bib id="b96"><reftxt><refau><snm>Miura</snm>, <fnm>P.</fnm></refau>, <refau><snm>Amirouche</snm>, <fnm>A.</fnm></refau>, <refau><snm>Clow</snm>, <fnm>C.</fnm></refau>, <refau><snm>Belanger</snm>, <fnm>G.</fnm></refau> &amp; <refau><snm>Jasmin</snm>, <fnm>B.J.</fnm></refau> <atl>Brain-derived neurotrophic factor expression is repressed during myogenic differentiation by miR-206</atl>. <jtl>J. Neurochem.</jtl> <vid>120</vid>, <ppf>230</ppf>&ndash;<ppl>238</ppl> (<cd year="2012">2012</cd>).</reftxt></bib>
<bib id="b97"><reftxt><refau><snm>Radzikinas</snm>, <fnm>K.</fnm></refau> <i>et al</i>. <atl>A Shh/miR-206/BDNF cascade coordinates innervation and formation of airway smooth muscle</atl>. <jtl>J. Neurosci.</jtl> <vid>31</vid>, <ppf>15407</ppf>&ndash;<ppl>15415</ppl> (<cd year="2011">2011</cd>).</reftxt></bib>
<bib id="b98"><reftxt><refau><snm>Wang</snm>, <fnm>Q.T.</fnm></refau> <i>et al</i>. <atl>A genome-wide study of gene activity reveals developmental signaling pathways in the preimplantation mouse embryo</atl>. <jtl>Dev. Cell</jtl> <vid>6</vid>, <ppf>133</ppf>&ndash;<ppl>144</ppl> (<cd year="2004">2004</cd>).</reftxt></bib>
<bib id="b99"><reftxt><refau><snm>Potireddy</snm>, <fnm>S.</fnm></refau>, <refau><snm>Vassena</snm>, <fnm>R.</fnm></refau>, <refau><snm>Patel</snm>, <fnm>B.G.</fnm></refau> &amp; <refau><snm>Latham</snm>, <fnm>K.E.</fnm></refau> <atl>Analysis of polysomal mRNA populations of mouse oocytes and zygotes: dynamic changes in maternal mRNA utilization and function</atl>. <jtl>Dev. Biol.</jtl> <vid>298</vid>, <ppf>155</ppf>&ndash;<ppl>166</ppl> (<cd year="2006">2006</cd>).</reftxt></bib>
<bib id="b100"><reftxt><refau><snm>Rouhana</snm>, <fnm>L.</fnm></refau> &amp; <refau><snm>Wickens</snm>, <fnm>M.</fnm></refau> <atl>Autoregulation of GLD-2 cytoplasmic poly(A) polymerase</atl>. <jtl>RNA</jtl> <vid>13</vid>, <ppf>188</ppf>&ndash;<ppl>199</ppl> (<cd year="2007">2007</cd>).</reftxt></bib>
<bib id="b101"><reftxt><refau><snm>Graindorge</snm>, <fnm>A.</fnm></refau>, <refau><snm>Thuret</snm>, <fnm>R.</fnm></refau>, <refau><snm>Pollet</snm>, <fnm>N.</fnm></refau>, <refau><snm>Osborne</snm>, <fnm>H.B.</fnm></refau> &amp; <refau><snm>Audic</snm>, <fnm>Y.</fnm></refau> <atl>Identification of post-transcriptionally regulated <i>Xenopus tropicalis</i> maternal mRNAs by microarray</atl>. <jtl>Nucleic Acids Res.</jtl> <vid>34</vid>, <ppf>986</ppf>&ndash;<ppl>995</ppl> (<cd year="2006">2006</cd>).</reftxt></bib>
<bib id="b102"><reftxt><refau><snm>Rouget</snm>, <fnm>C.</fnm></refau> <i>et al</i>. <atl>Maternal mRNA deadenylation and decay by the piRNA pathway in the early <i>Drosophila</i> embryo</atl>. <jtl>Nature</jtl> <vid>467</vid>, <ppf>1128</ppf>&ndash;<ppl>1132</ppl> (<cd year="2010">2010</cd>).</reftxt></bib>
<bib id="b103"><reftxt><refau><snm>Giraldez</snm>, <fnm>A.J.</fnm></refau> <i>et al</i>. <atl>Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs</atl>. <jtl>Science</jtl> <vid>312</vid>, <ppf>75</ppf>&ndash;<ppl>79</ppl> (<cd year="2006">2006</cd>).</reftxt></bib>
<bib id="b104"><reftxt><refau><snm>Staton</snm>, <fnm>A.A.</fnm></refau>, <refau><snm>Knaut</snm>, <fnm>H.</fnm></refau> &amp; <refau><snm>Giraldez</snm>, <fnm>A.J.</fnm></refau> <atl>miRNA regulation of Sdf1 chemokine signaling provides genetic robustness to germ cell migration</atl>. <jtl>Nat. Genet.</jtl> <vid>43</vid>, <ppf>204</ppf>&ndash;<ppl>211</ppl> (<cd year="2011">2011</cd>).</reftxt></bib>
<bib id="b105"><reftxt><refau><snm>Hilgers</snm>, <fnm>V.</fnm></refau> <i>et al</i>. <atl>Neural-specific elongation of 3&prime; UTRs during <i>Drosophila</i> development</atl>. <jtl>Proc. Natl. Acad. Sci. USA</jtl> <vid>108</vid>, <ppf>15864</ppf>&ndash;<ppl>15869</ppl> (<cd year="2011">2011</cd>).</reftxt></bib>
<bib id="b106"><reftxt><refau><snm>Ule</snm>, <fnm>J.</fnm></refau> <i>et al</i>. <atl>An RNA map predicting Nova-dependent splicing regulation</atl>. <jtl>Nature</jtl> <vid>444</vid>, <ppf>580</ppf>&ndash;<ppl>586</ppl> (<cd year="2006">2006</cd>).</reftxt></bib>
<bib id="b107"><reftxt><refau><snm>Bennett</snm>, <fnm>C.L.</fnm></refau> <i>et al</i>. <atl>A rare polyadenylation signal mutation of the <i>FOXP3</i> gene (AAUAAA&rarr;AAUGAA) leads to the IPEX syndrome</atl>. <jtl>Immunogenetics</jtl> <vid>53</vid>, <ppf>435</ppf>&ndash;<ppl>439</ppl> (<cd year="2001">2001</cd>).</reftxt></bib>
<bib id="b108"><reftxt><refau><snm>Montero</snm>, <fnm>L.</fnm></refau> &amp; <refau><snm>Nagamine</snm>, <fnm>Y.</fnm></refau> <atl>Regulation by p38 mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent <i>in vitro</i> cell invasion</atl>. <jtl>Cancer Res.</jtl> <vid>59</vid>, <ppf>5286</ppf>&ndash;<ppl>5293</ppl> (<cd year="1999">1999</cd>).</reftxt></bib>
<bib id="b109"><reftxt><refau><snm>Rimokh</snm>, <fnm>R.</fnm></refau> <i>et al</i>. <atl>Rearrangement of CCND1 (BCL1/PRAD1) 3&prime; untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias</atl>. <jtl>Blood</jtl> <vid>83</vid>, <ppf>3689</ppf>&ndash;<ppl>3696</ppl> (<cd year="1994">1994</cd>).</reftxt></bib>
<bib id="b110"><reftxt><refau><snm>Sibley</snm>, <fnm>C.R.</fnm></refau> &amp; <refau><snm>Wood</snm>, <fnm>M.J.</fnm></refau> <atl>The miRNA pathway in neurological and skeletal muscle disease: implications for pathogenesis and therapy</atl>. <jtl>J. Mol. Med.</jtl> <vid>89</vid>, <ppf>1065</ppf>&ndash;<ppl>1077</ppl> (<cd year="2011">2011</cd>).</reftxt></bib>
<bib id="b111"><reftxt><refau><snm>Jackson</snm>, <fnm>R.J.</fnm></refau> <atl>Alternative mechanisms of initiating translation of mammalian mRNAs</atl>. <jtl>Biochem. Soc. Trans.</jtl> <vid>33</vid>, <ppf>1231</ppf>&ndash;<ppl>1241</ppl> (<cd year="2005">2005</cd>).</reftxt></bib>
<bib id="b112"><reftxt><refau><snm>Pestova</snm>, <fnm>T.V.</fnm></refau> &amp; <refau><snm>Hellen</snm>, <fnm>C.U.</fnm></refau> <atl>Functions of eukaryotic factors in initiation of translation</atl>. <jtl>Cold Spring Harb. Symp. Quant. Biol.</jtl> <vid>66</vid>, <ppf>389</ppf>&ndash;<ppl>396</ppl> (<cd year="2001">2001</cd>).</reftxt></bib>
<bib id="b113"><reftxt><refau><snm>Sachs</snm>, <fnm>A.</fnm></refau> <atl>Physical and functional interactions between the mRNA cap structure and the poly(A) tail</atl>. in <jtl>Translational Control of Gene Expression</jtl> (eds. Sonenberg, N., Hershey, John W.B. &amp; Mathews, M.) Ch. 10, <ppf>447</ppf>&ndash;<ppl>465</ppl> (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, <cd year="2000">2000</cd>).</reftxt></bib>
<bib id="b114"><reftxt><refau><snm>Preiss</snm>, <fnm>T.</fnm></refau> &amp; <refau><snm>Hentze</snm>, <fnm>W.M.</fnm></refau> <atl>Starting the protein synthesis machine: eukaryotic translation initiation</atl>. <jtl>Bioessays</jtl> <vid>25</vid>, <ppf>1201</ppf>&ndash;<ppl>1211</ppl> (<cd year="2003">2003</cd>).</reftxt></bib>
<bib id="b115"><reftxt><refau><snm>Sonenberg</snm>, <fnm>N.</fnm></refau> &amp; <refau><snm>Hinnebusch</snm>, <fnm>A.G.</fnm></refau> <atl>Regulation of translation initiation in eukaryotes: mechanisms and biological targets</atl>. <jtl>Cell</jtl> <vid>136</vid>, <ppf>731</ppf>&ndash;<ppl>745</ppl> (<cd year="2009">2009</cd>).</reftxt></bib>
<bib id="b116"><reftxt><refau><snm>Dickson</snm>, <fnm>K.S.</fnm></refau>, <refau><snm>Thompson</snm>, <fnm>S.R.</fnm></refau>, <refau><snm>Gray</snm>, <fnm>N.K.</fnm></refau> &amp; <refau><snm>Wickens</snm>, <fnm>M.</fnm></refau> <atl>Poly(A) polymerase and the regulation of cytoplasmic polyadenylation</atl>. <jtl>J. Biol. Chem.</jtl> <vid>276</vid>, <ppf>41810</ppf>&ndash;<ppl>41816</ppl> (<cd year="2001">2001</cd>).</reftxt></bib>
<bib id="b117"><reftxt><refau><snm>Benoit</snm>, <fnm>P.</fnm></refau>, <refau><snm>Papin</snm>, <fnm>C.</fnm></refau>, <refau><snm>Kwak</snm>, <fnm>J.E.</fnm></refau>, <refau><snm>Wickens</snm>, <fnm>M.</fnm></refau> &amp; <refau><snm>Simonelig</snm>, <fnm>M.</fnm></refau> <atl>PAP- and GLD-2-type poly(A) polymerases are required sequentially in cytoplasmic polyadenylation and oogenesis in <i>Drosophila</i></atl>. <jtl>Development</jtl> <vid>135</vid>, <ppf>1969</ppf>&ndash;<ppl>1979</ppl> (<cd year="2008">2008</cd>).</reftxt></bib>
<bib id="b118"><reftxt><refau><snm>Jenal</snm>, <fnm>M.</fnm></refau> <i>et al</i>. <atl>The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites</atl>. <jtl>Cell</jtl> <vid>149</vid>, <ppf>538</ppf>&ndash;<ppl>553</ppl> (<cd year="2012">2012</cd>).</reftxt></bib></bibl></bm></article>
